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SUMMARY 
Long-distance RNA transport enables local protein synthesis at metabolically-
active sites distant from the nucleus. This process ensures an appropriate spatial 
organization of proteins, vital to polarized cells such as neurons. Here, we 
present a mechanism for RNA transport in which RNA granules “hitchhike” on 
moving lysosomes. In vitro biophysical modeling, live-cell microscopy, and 
unbiased proximity labeling proteomics reveal that annexin A11 (ANXA11), an 
RNA granule-associated phosphoinositide-binding protein, acts as a molecular 
tether between RNA granules and lysosomes. ANXA11 possesses an N-terminal 
low complexity domain, facilitating its phase separation into membraneless RNA 
granules, and a C-terminal membrane binding domain, enabling interactions with 
lysosomes. RNA granule transport requires ANXA11, and amyotrophic lateral 
sclerosis (ALS) mutations impair RNA granule transport in neurons by disrupting 
their interactions with lysosomes. Thus, ANXA11 mediates neuronal RNA 
transport by tethering RNA granules to actively-transported lysosomes, 
performing a critical cellular function that is disrupted in ALS. 
 
INTRODUCTION 
Many proteins within cells are translated locally rather than trafficked from their 
site of synthesis to their final destination. Neurons, which have long axons and 
dendrites, rely on local translation for numerous cell-specific functions (Glock et al., 
2017; Jung et al., 2012; Krichevsky et al., 2001; Leung et al., 2006; Martin and 
Ephrussi, 2009; Wong et al., 2017; Yao et al., 2006; Zheng et al., 2001). Local 
translation requires long-distance transport of RNA from the nucleus to distal parts of 
the cell.  
For membrane-bound organelles such as mitochondria and endosomes, the 
microtubule-based motors kinesin and dynein interact either directly or indirectly with 
membrane proteins and lipids to enable long-range transport. RNAs, however, do not 
usually exist in membrane-enclosed structures. Instead, they interact with with RNA-
binding proteins (RBPs), which self-organize into phase separated structures called 
RNA granules (Weber and Brangwynne, 2012). RNA granules have long been observed 
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to traffic within neuronal axons and dendrites (Knowles et al., 1996; Gopal et al., 2017). 
While their transport requires both microtubules and motor proteins, how membraneless 
RNA granules are tethered to transport machinery remains incompletely understood 
(Clark et al. 2007; Davidovic et al. 2007; Dictenberg et al. 2008; Dienstbier et al. 2009; 
Dix et al. 2013; Gaspar et al. 2016; Gagnon et al. 2013). 
Mutations in RBPs, molecular motors, and microtubule components have all 
been linked to neurological diseases, highlighting the critical contributions of RNA 
transport and metabolism to long-term neuronal integrity (Baird, 2013; Bakthavachalu et 
al.,2018; Chevalier-Larsen and Holzbaur, 2006; Fallini et al., 2011; Hirokawa et al., 
2010; Puls et al., 2003; Ramaswami et al. 2013). In particular, numerous causative 
mutations for amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD), two 
related adult-onset neurodegenerative diseases, fall within these gene groups (Van 
Deerlin et al., 2008; Kim et al., 2013; Münch et al., 2005; Nicolas et al., 2018; Vance et 
al., 2009). The bulk of other genes linked to familial ALS/FTD encode proteins that 
regulate lysosomal biology (Baker et al., 2006; Guerreiro et al., 2015; Pottier et al., 
2015; Renton et al., 2011; Shi et al., 2018; Skibinski et al., 2005; Ward et al., 2017). 
Lysosomes and lysosome-related organelles are coupled to motor proteins through 
well-characterized adapter proteins, and like RNA granules, lysosomes traffic long 
distances within neuronal processes (Farías et al., 2017; Fu and Holzbaur, 2014; Pu et 
al., 2015). 
Recently, it has become clear that not all cargos directly interact with motor 
proteins during long-range transport. Rather, some cargos are indirectly transported 
along microtubule networks by docking onto other membrane-bound organelles such as 
endosomes, a process known as “hitchhiking” (Guimaraes et al., 2015; Salogiannis et al 
2016; Salogiannis and Reck-Peterson, 2017). Endosomal hitchhiking appears to be the 
primary mechanism by which peroxisomes, lipid droplets, and ER travel long-distances 
within filamentous fungi. Interestingly, RNA granules also hitchhike on moving 
endosomes in filamentous fungi during long-distance trafficking, hinting at the possibility 
of similar phenomena in higher-order organisms (Baumann et al., 2012; Higuchi et al 
2014; Pohlmann et al., 2015).  
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In this study, we show that RNA granules hitchhike on lysosomes for long-
distance trafficking in mammalian cells. Using a combination of proximity labeling 
proteomics, live-cell imaging, and in vitro assays, we then identify the ALS-associated 
protein ANXA11 as a molecular tether that can dynamically couple RNA granules with 
lysosomes. ALS-associated mutations in ANXA11 disrupt docking between RNA 
granules and lysosomes, consequently impeding RNA granule transport in neurons in 
vitro and in vivo. Together, these findings identify the lysosome as a key player in 
neuronal RNA transport, characterize how ANXA11 enables interactions between 
membraneless RNA granules and lysosomes, and provide mechanistic evidence for the 
involvement of altered RNA transport in ALS pathogenesis. 
 
RESULTS 
RNA granules hitchhike on motile lysosomes in mammalian cells 
Using live cell microscopy, we explored whether RNA granules could move within 
mammalian cells through association with motile, membranous organelles. Following 
heat shock, G3BP1-labeled RNA granules predominately co-localized with markers for 
lysosomes (LAMP1) and ER (SEC61) in U2OS cells (Figure1A, Supplemental Figure 
1A, B), and co-trafficked with lysosomes (Figure 1B, Supplemental Figure 1C, D, 
Supplemental Video 1). Lysosomes and juxta-positioned RNA granules moved along 
microtubules, and their motility was blocked by nocodazole-induced microtubule 
depolymerization (Figure 1C and Supplemental Figure 1E,F). Thus, stress-induced RNA 
granules co-traffic with lysosomes during microtubule-dependent transport. 
 Next, we analyzed RNA granule and LAMP1 dynamics in cultured primary 
cortical neurons, which constitutively transport these structurs within axons. In neurons, 
LAMP1-positive vesicles include both degradative lysosomes and non-acidic endo-
lysosomes (Cheng et al., 2018; Farías et al., 2017), but for simplicity, we hereafter refer 
to all LAMP1 positive structures as lysosomes. Within axons, lysosomes co-trafficked 
with RNA granules labeled with G3BP1 (Sahoo et al. 2018), TDP-43 (Alami et al., 2014; 
Gopal et al., 2017), and CAPRIN1 (Nakayama et al., 2017) (Figure 1D, Supplemental 
Figure 1J, K). Lysosomes also co-trafficked with actin-MS2/MCP (Figure 1E, 
supplemental Figure 1I), a probe that labels actin mRNA, one of the most abundant 
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mRNAs in axons (Bassell et al., 1998). Of note, although most anterograde and 
retrograde moving RNA granules clearly co-trafficked with lysosomes (Figure 1D,E), 
only a fraction of lysosomes co-trafficked with RNA granules (Supplemental Figure 
1H,L,M). Inhibition of motor-dependent lysosomal movement blocked RNA granule 
transport (Figure 1D, E, Supplemental Figure 1N). These results confirm that trafficking 
of RNA granules and lysosomes during long-range axonal transport are intimately 
linked. 
 In confocal images, RNA granules and lysosomes were closely apposed (Figure 
1F, top panel). Correlative light-electron microscopy (CLEM) imaging of these structures 
confirmed that lysosomes and RNA granules were tightly associated, with no evidence 
of lysosomal engulfment of the RNA granule (as would be expected during 
autophagy)(Buchan et al., 2013) (Figure 1F, bottom image). These results support a 
model in which lysosomes serve as a vehicle for RNA granule transport, and suggest 
the presence of a molecular tether between RNA granules and lysosomes.   
 
Identification of ANXA11 as a mediator of RNA granule-lysosome associations  
To identify potential proteins that tether RNA granules to lysosomes, we used 
ascorbate peroxidase (APEX) proximity labeling proteomics (Hung et al., 2016) to label 
and catalog the interactome of LAMP1-positive lysosomes (LAMP1-APEX2 probe) in 
human iPSC-derived neurons (i3Neurons) (Fernandopulle et al., 2018) (Figure 2A, B). 
Immunofluorescence staining of biotinylated prey confirmed that we could successfully 
label proximal lysosome-interacting proteins in i3Neurons and axonal compartments 
(Figure 2C). We identified ~130 proteins as LAMP1-APEX2 prey by proteomic mass 
spectrometry in i3Neurons (using nuclear export signal APEX (NES-APEX2) as a spatial 
reference), representing proteins that are specifically associated with lysosomes (Figure 
2D). Gene Ontology-term analysis of these prey showed substantial labeling of 
lysosomal proteins, as expected, along with a significant enrichment of RNA granule-
associated proteins (Figure 2E). To identify proteins that might function as a molecular 
tether between lysosomes and RNA granules, we cross-referenced our list with a 
previously generated list of RNA granule interacting proteins that used G3BP1-APEX2 
as a bait (Markmiller et al., 2018) (Figure 2F). Through this analysis, we identified six 
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putative interacting partners of both lysosomes and RNA granules. Of these, annexin 
A11 (ANXA11) was the highest-ranked lysosome-interacting protein based on LAMP1-
APEX2 proteomics. 
 Mutations in ANXA11 are associated with ALS, a neurodegenerative disease in 
which dysfunction of lysosomal and RNA granule biology play causal roles (Smith et al., 
2017; Tsai et al., 2018; Zhang et al., 2018a). We performed structural modeling of 
ANXA11 as a first step in its characterization (Figure 2G). ANXA11, like other annexin 
family members, contains four C-terminal calcium-dependent membrane-binding 
annexin domains. Unlike most other annexin family members, however, ANXA11 also 
has a long N-terminal low-complexity region (LCR) (Figure 2H). LCRs are common to 
RNA granule-associated proteins, and facilitate formation of transient phase-separated 
assemblies that shelter associated RNAs (Hyman and Brangwynne, 2011; Hyman et al., 
2014; Weber and Brangwynne, 2012). Thus, ANXA11 contains structural features that 
could enable both binding to lipid membranes (e.g., lysosomes) and intercalation within 
phase-separated RNA granules.  
We used a series of in vitro assays to characterize the biophysical properties of 
ANXA11. At high concentrations, or when incubated with 10% dextran (a molecular 
crowding agent), purified ANXA11 formed phase-separated droplets that grew in size 
and fused with each other over time (Figure 2I, Supplemental Figure 2A). A similar 
change occurred when ANXA11 was transitioned from 4oC to 25oC. We performed the 
same assays with purified ANXA11 N-terminus (amino acids 1-185; the LC region) and 
ANXA11 C-terminus (amino acids 186-502; the annexin region). As predicted by our 
structural models, the N-terminal LCR region of ANXA11 was necessary and sufficient 
for phase separation (Figure 2J). These results indicate that ANXA11 can form phase-
separated droplets similar to traditional RNA granule proteins, and that the N-terminus 
of ANXA11 confers this property.  
           We next investigated whether purified ANXA11 could bind membrane lipids. 
Structural modeling predicted that calcium binding conferred a positive surface charge 
to ANXA11’s annexin domains (Figure 2K), which could potentiate binding of ANXA11 to 
negatively-charged, membrane phospholipids. Using a protein lipid overlay assay, we 
found that ANXA11 bound several lysosome-enriched, negatively-charged 
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phosphatidylinositols in a Ca2+-dependent manner (Figure 2L). Three-dimensional lipid 
flotation lipid overlay assays confirmed that ANXA11 co-floated with PI(3,5)P2 containing 
liposomes (Figure 2M, N) and interacted with PI3P-containing liposomes in a Ca2+-
dependent manner (Fig. 2O). We further showed ANXA11 required PI3P to bind 
liposomes at physiological calcium concentrations (Fig. 2P, Q). Together, these in vitro 
studies demonstrate that ANXA11 possesses biophysical properties that enable it to 
interact with both RNA granules and lysosomes, consistent with structural predictions 
and unbiased proteomic results. 
 
ANXA11 interacts with both RNA granules and lysosomes in cells  
 Based on its structural and biophysical attributes, we speculated that ANXA11 
might incorporate into RNA granules through its phase separating properties and 
additionally interact with lysosomes through its lipid binding properties. Basic 
characteristics of phase-separated RNA granules in cells include dynamic structural 
associations (i.e., fission and fusion), rapid exchange between phase-separated and 
soluble states, and stress-induced oligomerization (i.e., “stress granule” formation) 
(Hyman and Brangwynne, 2011; Hyman et al., 2014). We found that ANXA11-mEmerald 
redistributed into spheroid structures following heat shock (Figure 3A). These stress-
induced structures had various liquid properties, including droplet fusion (Figure 3B, top 
panel) and rapid fluorescence recovery after photobleaching (Figure 3B, bottom panel 
and Figure 3C), the latter indicating rapid cycling of ANXA11 between phase-separated 
and soluble states. The N-terminal LC region of ANXA11 was sufficient for ANXA11 
puncta formation (Supplemental Figure 3A-C), consistent with its in vitro properties.  
 We then asked if ANXA11 co-localized with RNA stress granule markers in cells 
undergoing heat shock. Stress granules composed of G3BP1, TDP43 or mRNA labeled 
by Oligo-dT all contained ANXA11 signal (Figure 3D, Supplemental Figure 3D). 
Because the N-terminal LCR of ANXA11 conferred its phase separation properties, we 
speculated that this region also mediated interactions with RNA granules in cells. We 
found that the N-terminal LCR of ANXA11 was sufficient to localize mEmerald to stress 
granules in U2OS cells (albeit to a lower extent than full-length ANXA11), but that an 
ANXA11-mEmerald truncation mutant lacking the N-terminal LCR  was not (Figure 3E, 
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Supplemental 3E, 3F). These data indicate that ANXA11 incorporates into stress-
induced RNA granules following heat shock, that these granules represent 
heterogeneous, phase-separated assemblies, and that the N-terminal LCR of ANXA11 
is necessary and sufficient for RNA granule interactions. 
 We next examined whether ANXA11 interacted with lysosomes in living cells. 
Time-lapse imaging revealed that ANXA11-positive puncta localized to the surface of 
LAMP1-structures following heat shock in U2OS cells (Figure 3F and Supplemental 
Figure 3H) and primary neurons (Figure 3G, Supplemental 3G). Axonal ANXA11 puncta 
co-trafficked with lysosomes, as shown in kymographs (Figure 3H). As predicted by our 
structural modeling, the C-terminal annexin repeat domain was both necessary and 
sufficient for interactions between ANXA11 and lysosomes (Figure 3I). Taken together, 
these results indicate that ANXA11 interacts with both RNA granules and lysosomes 
within diverse cell types, and that these interactions are mediated by its N-terminal LCR 
and C-terminal annexin domains, respectively. 
 To further explore the interactive properties of lysosomes and ANXA11 in living 
cells, we used a FLIM-based FRET approach, which can be used to infer direct 
molecular interaction between two probes at nanometer scales. We found that the 
lifetime of the FRET donor ANXA11-mCerulean3 decreased (i.e., FRET efficiency 
increased) near the FRET acceptor LAMP1-YFP, suggesting that ANXA11 and 
lysosomes tightly associate with each other (Figure 3J). Interestingly, the FRET 
efficiency increased further in the presence of ML-SA1, a lysosomal calcium channel 
agonist (Figure 3J, K), suggesting that ANXA11 and lysosomes more strongly interact 
following Ca2+ release from lysosomes. Supporting this observation, treatment with 
BAPTA-AM, a selective, permeable Ca2+ chelator that removes free Ca2+ from the 
cytoplasm, decreased the FRET efficiency (Figure 3J,K). Treatment with YM201636, 
which inhibits the formation of PI(3,5)P2, also decreased the FRET efficiency, 
suggesting that ANXA11 and lysosomes depend on PI(3,5)P2 for their interaction (Figure 
3J,K). Therefore, the interaction between ANXA11 and lysosomal membranes in cells 
occurs in a calcium- and phospholipid- dependent manner.  
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ALS-associated mutations in ANXA11 disrupt RNA granule dynamics and 
interactions 
Since mutations in both the N- and C-terminal domains of ANXA11 are 
associated with familial ALS, we investigated whether these mutations altered 
properties of RNA granules in living cells. FRAP analysis of ANXA11 dynamics showed 
that granules containing p.D40G-ANXA11, p.R235Q-ANXA11 or p.R346C-ANXA11 
(Supplemental Figure 4A) had impaired fluorescence recovery relative to WT ANXA11 
(Figure 4A, B). This result suggests that ALS mutations cause ANXA11 to become more 
stably associated with RNA granules and/or impair their phase transitioning.  
To determine whether this effect was intrinsic to ANXA11, we performed in vitro 
assays using purified WT, p.D40G, and p.R346C forms of ANXA11. We transitioned the 
temperature between 4oC and 25oC over repeated cycles and observed the proteins’ 
ability to phase partition into droplets. Both p.D40G and p.R346C mutants exhibited 
accelerated phase transitioning from soluble protein to insoluble gels upon warming, 
and an impaired ability to recover into liquid states upon re-cooling (Figure 4C). 
Therefore, ALS-associated ANXA11 mutations promote phase transitions from liquid to 
more stable gel-like states within ANXA11 droplets.  
Next, we fused a light-induced oligomerization domain (CRY2-mCherry) to the N-
terminus of WT and mutant ANXA11 proteins (Opto-ANXA11), allowing us to precisely 
regulate assembly/disassembly of ANXA11 phase condensates using light. Exposure of 
wild-type Opto-ANXA11 to 488-nm light triggered multimerization faster than Opto-
mCherry (Figure 4D, 4E), and the N-terminal LCR of ANXA11 was necessary and 
sufficient for Opto-ANXA11 condensation (Supplemental Figure 4B, C). Thus, ANXA11 
potentiates light-induced phase condensation, similar to other RNA-granule proteins 
fused with CRY2 (Shin et al., 2017; Zhang et al., 2018b). All mutant Opto-ANXA11 
proteins tested formed condensates faster than WT-Opto-ANXA11 (Figure 4D, E). 
Moreover, mutant Opto-ANXA11 condensates disassembled substantially slower than 
WT-Opto-ANXA11 following discontinuation of 488-nm light stimulation (Figure 4D, F). 
Together, these results suggest that N- and C-terminal ALS-associated ANXA11 
mutations promote phase transitions from liquid-liquid droplets to gel-like states, and 
impair reversal of gel-like states once formed.    
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To test whether mutations in ANXA11 altered its ability to interact with RNA 
granules, we quantified the extent of co-localization of ANXA11 and its mutants with 
RNA granules following heat shock in living cells. Whereas the N-terminal p.D40G-
ANXA11 mutation had no effect on RNA granule co-localization, C-terminal p.R235Q-
ANXA11 and p.R346C-ANXA11 mutations dramatically reduced co-localization of 
ANXA11 with RNA granules (Figure 4G, H, Supplemental Figure 4D, E). ALS-
associated ANXA11 mutations also altered the phase transition properties of other RNA 
granule-associated proteins, slowing both FRAP kinetics of G3BP1 and the disassembly 
rate of G3BP1 granules following stress release (Supplemental Figure 4F-I). Thus, ALS-
associated mutations in ANXA11 interfere with ANXA11’s ability to interact and 
intercalate with phase-separated RNA granules, which subsequently impacts RNA 
granule properties. 
 
ALS-associated mutations in ANXA11 disrupt its interactions with lysosomes  
 We next asked whether ALS-associated ANXA11 mutations altered lysosome 
interactions. Light-induced oligomerization of Opto-ANXA11 caused rapid association of 
Opto-ANXA11 condensates with lysosomes (Figure 5A, B). The C-terminal annexin-
repeat domain of ANXA11 was necessary and sufficient for Opto-ANXA11 association 
with lysosomes (Supplemental Figure 5A, B). Notably, Opto-ANXA11 mutants harboring 
ALS-associated C-terminal mutations failed to interact with lysosomes (Figure 5A, B). 
C-terminal ALS-associated mutations also impaired associations between ANXA11-
mEmerald condensates and lysosomes following stress (Figure 5C, D). Therefore, as 
predicted by structural modeling, ANXA11 interacts with lysosomes through its C-
terminal domain, a process disrupted by ALS-associated C-terminal mutations.  
 We further tested whether ALS-associated mutations altered axonal co-trafficking 
of ANXA11 with lysosomes in cultured primary neurons. As predicted, mutations in the 
C-terminus of ANXA11 impaired ANXA11’s ability to interact with motile lysosomes in 
axons (Figure 5E, F) while having no substantial effect on lysosome trafficking 
(Supplemental Figure 5C). Taken together, these data suggest that ALS-associated C-
terminal mutations impair the ability of ANXA11 to associate with lysosomes, and both 
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C- and N-terminal mutations impact properties of ANXA11 within phase-separated 
structures. 
 
ANXA11 acts as an adaptor between RNA granules and lysosomes 
Since ANXA11 interacts with both RNA granules and lysosomes, we speculated 
that ANXA11 might function as a molecular tether to couple RNA granules with 
lysosomes. To explore this possibility, we expressed Opto-ANXA11 in U2OS cells and 
monitored lysosome and RNA granule dynamics using time-lapse confocal microscopy. 
We reasoned light-induced oligomerization of ANXA11 might facilitate the docking of 
RNA granules with lysosomes, since phase-separated ANXA11 has an increased affinity 
for both structures. When we stimulated Opto-ANXA11 expressing cells with 488 nm 
light, we saw G3BP1-labeled RNA granules associating with Opto-ANXA11-bound 
lysosomes (Figure 6A, Supplemental Figure 6A, Video 3), and an increase in the 
number of RNA granule-lysosome interactions (Supplemental Figure 6B).  
We then co-imaged ANXA11, RNA granules and lysosomes in heat-shocked 
U2OS cells to further define their spatial relationships. ANXA11 was present in the core 
of G3BP1-labeled RNA granules and additionally displayed a peripheral localization 
pattern that extended beyond the boundary of G3BP1 into the region labeled by LAMP1 
(Figure 6B), consistent with a potential tethering function. 
Next, we asked if ANXA11 was sufficient to promote interactions of RNA granules 
with lysosome-like vesicles in an in vitro reconstitution assay. We purified stress-
induced RNA granule cores from cells (Jain et al. 2016; Khong et al. 2017; Wheeler et 
al. 2017; Khong et al. 2018), and mixed these granules with PI3P-containing liposomes 
in the presence or absence of ANXA11 and/or calcium (Figure 6C).  In the absence of 
ANXA11 or calcium, G3BP1-positive RNA granules failed to interact with liposomes. 
However, addition of both ANXA11 and calcium promoted contact between G3BP1-
positive RNA granules and liposomes (Figure 6D, E). These results support a model in 
which ANXA11 directly functions as a molecular tether to facilitate binding of RNA 
granules to lysosomes.  
To determine if ANXA11 co-localized with co-motile RNA granules and lysosomes 
in axons, we performed time-lapse imaging of cultured rodent neurons. Similar to stress 
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granules, ANXA11 co-localized and co-trafficked with motile RNA granule/lysosome 
assemblies in axons (Figure 6F, Supplemental Video 4). 
We then asked if ANXA11 was necessary to facilitate axonal RNA 
granule/lysosomal hitchhiking. ANXA11 knockdown in primary rodent neurons 
(Supplemental Figure 6D) substantially impaired axonal RNA granule/lysosome 
hitchhiking (Figure 6G and H) without altering axonal lysosome transport itself 
(Supplemental Figure 6E). To determine if ANXA11 knockdown impaired RNA delivery 
to distal regions of the cell, we quantified levels of actin mRNA in growth cones using 
single molecule FISH (smFISH). We found that ANXA11 knockdown reduced levels of 
actin mRNA in growth cones, consistent with impaired long-distance axonal mRNA 
transport (Figure 6I, J). Together, these data indicate that ANXA11 is sufficient to 
facilitate tethering of RNA granules to lysosomes, and is necessary for axonal RNA 
granule hitchhiking and delivery of mRNA to distal locations within neurons. 
 
ALS-associated ANXA11 mutations disrupt RNA granule hitchhiking on 
lysosomes 
Because C-terminal mutations interfered with the ability of ANXA11 to interact 
with lysosomes, we tested whether these mutations disrupted RNA granule-lysosome 
interactions. Indeed, lysosomes made fewer contacts with RNA granules in cells 
expressing ANXA11 with C-terminal mutations (Supplemental Figure 6F-H). These 
findings predict that ALS-associated ANXA11 mutations, which interfere with the ability 
of ANXA11 to efficiently interact with RNA granules and lysosomes, also disrupt 
hitchhiking of RNA granules on lysosomes during transport. 
 We used live cell microscopy to test whether ANXA11 mutations altered RNA 
granule hitchhiking on lysosomes. In control neurons, ANXA11 co-trafficked with both 
mRNA (Figure 7A) and RNA granule markers (Supplemental Figure 7A, Video 4). As 
predicted, the C-terminal ALS-associated ANXA11 mutation p.R235Q drastically 
reduced the number of trafficking RNA granules on lysosomes in axons (Figure 7A,B 
and Supplemental 7B, Video 5). Importantly, mutant ANXA11 expression did not alter 
axonal lysosome transport itself (Supplemental Figure 5C). Similar to our observations 
in ANXA11 knockdown neurons, we found that ANXA11 mutations reduced levels of 
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actin mRNA in growth cones per smFISH imaging (Figure 7C, D). These data indicate 
that ALS-associated mutations impair axonal RNA granule transport, as well as delivery 
of mRNAs to distal regions of the cell. 
 To determine whether ANXA11 mutations altered RNA granule axonal trafficking 
in vivo, we co-imaged lysosomes, ANXA11 and CAPRIN1 (an axonal RNA granule 
protein) in axons of live zebrafish neurons (Figure 7E). Both anterograde- and 
retrograde-moving RNA granules co-trafficked with lysosomes (Figure 7F, Supplemental 
Video 6), and numerous motile RNA granules also co-localized with detectable levels of 
ANXA11 (Figure 7G, Supplemental Video 7). Similar to observations in primary rat 
neurons, ALS-associated ANXA11 mutations interfered with RNA granule motility 
(Figure 7H, Supplemental Figure E-G). Therefore, in primary rat neurons and in an in 
vivo zebrafish model, ANXA11 co-localizes with RNA granules and lysosomes during 
axonal transport. Moreover, ALS-associated ANXA11 mutations disrupt this trafficking by 
preventing RNA granule hitchhiking on lysosomes. 
 
DISCUSSION 
 Polarized cells such as neurons rely on active, microtubule-directed RNA 
transport to facilitate local protein translation at subcellular locations far from the 
nucleus. Here, we discovered that membraneless RNA granules hitchhike on moving 
lysosomes during long-distance transport in both non-polarized cells and neurons, 
consistent with similar recent observations by others (Gershoni-Emek et al., 2018; Cioni 
et al., 2019). We then identified ANXA11 as a molecular tether that couples RNA 
granules to lysosomes, thus mediating efficient long-distance transport of RNA. Finally, 
we showed that ALS-associated ANXA11 mutations alter ANXA11’s biophysical and 
cellular properties, impeding axonal RNA transport. Based on our observations, we 
propose a mechanism governing active RNA granule transport in which lysosomes 
recruit RNA granules through the tethering function of ANXA11, facilitating RNA granule 
transport to distal reaches of the cell.  
 For simplicity, we referred to all LAMP1-positive vesicles as lysosomes, though 
recent evidence suggests that LAMP1-positive structures in neurons encompass a 
heterogenous group of proteolytically-active and inactive vesicles (Cheng et al., 2018; 
 14 
Farías et al., 2017). We observed that only a fraction of LAMP1-positive vesicles co-
trafficked with RNA granules, and it will be important to further characterize the precise 
nature of these LAMP1-positive organelles. For example, as anterograde-directed RNA 
granules presumably fuel local translation at distal sites, it is possible that their 
associated LAMP1-positive organelles are pH-neutral and non-degradative in function. 
By contrast, LAMP1-positive organelles near the soma have a lower pH and can either 
fuse with or mature into lysosomes with degradative activity (Farías et al., 2017). Our 
CLEM imaging showed that the bulk of RNA granules are not internalized within 
lysosomes, as would be expected if they had undergone bulk autophagy. However, the 
juxtaposition of lysosomes with RNA granules could provide an opportunity for localized 
internalization and degradation of portions of RNA granules (e.g. via piece-meal 
microautophagy). Alternatively, retrograde-directed RNA granules may function in a 
recycling capacity, in which no RNA granule internalization by LAMP1-positive 
organelles would occur.  
 Structural modeling of ANXA11 revealed several unique attributes suitable for its 
role in tethering RNA granules with lysosomes, and we found that these structural 
properties governed ANXA11’s overall function. Similar to many other RNA granule 
proteins, the N-terminus of ANXA11 has a prion-like low complexity domain. Such 
domains can facilitate context-dependent multimerization, which in turn triggers phase 
separation into liquid droplets and hydrogels. However, unlike any other RNA granule-
associated proteins described to date, ANXA11 also has a series of Ca2+ and lipid-
binding, C-terminal annexin repeats. This unique combination of a low-complexity 
domain and a Ca2+-dependent membrane binding domain allows ANXA11 to interact 
with both RNA granules and lysosomes. Interestingly, it was recently discovered that 
Ca2+-dependent clustering of synaptic vesicles is driven by phase separation of 
synapsin 1, a protein that, like ANXA11, can both bind membranes and undergo phase 
transitions (Milovanovic et al. 2018). It is possible that additional adapter proteins 
regulate interactions between other membraneless and membrane-bound organelles in 
similar ways. 
 We observed that ANXA11 interacted with lysosomes only in the presence of 
both Ca2+ and the membrane phosphoinositide PI(3,5)P2. Interestingly, PI(3,5)P2 is 
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enriched in late endosomes and lysosomes (Ikonomov et al., 2009; Michell et al., 2006), 
and is a known natural agonist of TRPML1, a major lysosomal calcium channel (Dong 
et al., 2010). Therefore, ANXA11 may bind to lysosomal membranes in response to the 
highly-regulated focal release of Ca2+ from TRPML channels. Such a mechanism could 
enable precise spatiotemporal recruitment and/or release of RNA granules. Indeed, we 
showed that a TRPML agonist can cause increased recruitment of ANXA11 to 
lysosomes. One possibility, therefore, is that RNA granule loading occurs at times and 
places of high TRPML1 activity, while RNA granule unloading occurs at times and 
places of TRPML1 inactivation. Molecular mediators of PI(3,5)P2 dynamics, such as the 
phosphatidylinositol-5-kinase PIKfyve, myotubularin family 3-phosphatases, and the 5-
phosphatase FIG4, could also be involved in ANXA11 regulation.  
 Analyzing the association of ANXA11 with RNA granules, we observed that 
ANXA11 localizes both within the core of RNA granules and at its periphery, extending 
to sites in close association with lysosomal membranes. Localization of ANXA11 to the 
peripheral regions of these granules could facilitate interactions with lysosomes or other 
ANXA11-studded RNA granules during fusion events. Indeed, we found that 
recombinant ANXA11 facilitated interactions between purified stress granule “cores” 
(Jain et al. 2016; Khong et al. 2017) and liposomes in vitro. Additionally, we observed 
stress-induced ANXA11 foci within cells that did not contain other markers of RNA 
granules. These ANXA11 foci fused with larger stress granules positive for both ANXA11 
and other stress granule markers. The explanation for these unexpected distribution 
characteristics of ANXA11 in granules remains to be further investigated, but various 
possibilities can be envisioned given the previously described hierarchical organization 
of proteins within stress granules (Jain et al., 2016). For example, ANXA11 might 
participate in promiscuous interactions with low-complexity domains in other granule 
proteins, it might have specific interactions with local structures in low complexity 
domains of other granule proteins, or it might interact primarily with granule-associated 
RNA secondary structures (Khong et al. 2018; Mittag and Parker, 2018; Langdon et al., 
2018; Van Treeck and Parker, 2018). Interestingly, prior global proteomic mapping of 
RNA binding proteins in cancer cells identified ANXA11 as an RNA binding protein 
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(Baltz et al., 2012). It remains unclear whether ANXA11 directly binds RNA, or interacts 
indirectly through intercalation into RNA granules. 
 Mutations in ANXA11 cause ALS and a related neurodegenerative disorder, 
frontotemporal dementia (FTD). Numerous mutations in ANXA11 have now been 
described by several different groups, and may account for up to 6% of familial ALS in 
Chinese populations (Smith et al., 2017; Tsai et al., 2018; Zhang et al., 2018a). 
Pathogenic mutations occur in both the N-terminal low complexity region and the C-
terminal membrane binding region. We found that these mutations altered several 
fundamental biophysical properties of ANXA11. Both N-terminal and C-terminal 
mutations increased the propensity of ANXA11 to form hydrogel-like structures, and C-
terminal mutations reduced the affinity of ANXA11 for phospholipid membranes.  
The overall impact of these mutation-induced biophysical changes had several 
consequences for RNA granule/lysosome behavior within cells. These mutations 
interfered with RNA granule/lysosome docking and increased the gel-like properties of 
ANXA11 and other associated RNA granule proteins in cells. C-terminal mutations had 
particularly deleterious effects on ANXA11 function, potentially because they altered 
both its phase separation properties and lysosomal interactions. Because we saw that 
ANXA11 knockdown reduced axonal RNA granule transport, it is likely that both loss-of-
function and gain-of-function mechanisms contribute to ALS pathogenesis in the setting 
of ANXA11 mutations.  We also showed that ANXA11 knockdown reduced delivery of 
essential mRNAs to distal regions of the neuron. We postulate that the consequences of 
even modestly-impaired RNA transport could, over time, lead to widespread disruption 
of neuronal homeostasis and potential dysregulation of synaptic activity. Concurrently, 
ANXA11 mutation-induced aggregates might sequester additional critical RNA granule 
proteins, including granule chaperones. This could lead to further dysregulation of RNA 
metabolism within affected cells.  
In summary, our study identifies a previously unrecognized relationship between 
lysosomal biology and RNA metabolism, and implicates dysfunctional RNA granule 
trafficking as a potential converging disease mechanism in ALS. Our findings further 
suggest the possibility of additional mechanistic relationships between other ALS-
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associated genes, including those regulating lysosomal homeostasis, docking and 
transport machinery, and/or the biophysical state of RNA granules. 
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FIGURE LEGENDS 
Figure 1. RNA granules hitchhike on motile lysosomes in mammalian cells 
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(A) RNA granule co-imaging with different organelles. U2OS cells expressing mCherry-
G3BP1 and different organelle markers were imaged live 30 minutes after heat shock 
(43oC). Organelle markers: LAMP1 – lysosome, Sec61 – ER, TOMM20 – mitochondria, 
SiT – Golgi, SKL – peroxisome, Rab5 – early endosome, Rab7 – late endosome, 
Rab11a – recycling endosome, Ensconsin – microtubule. Arrows point to lysosome-RNA 
granule contact sites. Scale bar: 2μm. See also Fig S1 A, B.  
(B) Percentage of RNA granules that co-traffic with different organelles from (A). N=7. 
(C) Time-lapse image sequence showing RNA granule (mCherry-G3BP1) co-trafficking 
with a lysosome (LAMP1-HaloTag) along a microtubule (Ensconsin-GFP) in U20S cells 
immediately after heat shock at 43oC. Scale bar: 1μm. See also Fig S1 F, Video1, 2.  
(D) Kymograph of RNA granules co-trafficking with lysosomes in axons. 
Axons of rat cortical neurons expressing LAMP1-HaloTag and mEmerald-G3BP1 were 
imaged at 100ms/frame for 30 seconds. Arrow points to a lysosome co-trafficking with a 
G3BP1-labeled structure. P50/p150Glued: Doxycycline-inducible expression of a p50 
dynactin subunit and the CC1 domain of the p150 glued subunit of dynactin was used to 
inhibit motor-directed transport of lysosomes. Scale bar: 5 μm. See also Fig S1 J, K. 
(E) Kymograph of mRNA co-trafficking with lysosomes in axons. 
Axons of rat cortical neurons expressing LAMP1-HaloTag, actin-24xMBS and MCP-
NLS-2xEGFP were imaged as in (D). Arrow points to a lysosome co-trafficking with actin 
mRNA. Scale bar: 5 μm. See also Fig S1 I. 
(F) CLEM images of an RNA granule associated with a lysosome. Upper panel shows 
the fluorescent image of a LAMP1-labeled lysosome and a G3BP1-labeled RNA 
granule. Lower panel shows the correlated electron microscopy image. L, lysosome; G, 
RNA granule. Scale bar: 1μm. 
 
Figure 2. Identification of ANXA11 as a potential mediator of RNA granule-
lysosome associations 
A-G.  Proximity labeling proteomic screen for lysosomal interacting proteins in 
i3Neurons.  
(A) Schematic of LAMP1-APEX2 bait.  
(B) Electron microscopy image of DAB precipitate generated by LAMP1-APEX2 (dark 
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contrast, arrow) surrounding lysosomes in i3Neurons. Scale bar: 100 nm. 
(C) Confocal immunofluorescence image of LAMP1-APEX2 biotinylated prey 
(streptavidin-488 staining) surrounding LAMP1-positive lysosomes in i3Neuron axons 
(Tuj1). Scale bar: 10 μm. 
(D) Plot showing statistically significant LAMP1-APEX2 enriched prey proteins from 
proximity-labeling proteomics in i3Neurons. n = 4, p values corrected for multiple 
comparisons.  
(E) Functional Annotation Clustering of DAVID Gene Ontology terms of Lamp1-APEX 
enriched prey.  
(F) Venn diagram of LAMP1-APEX2 hits versus G3BP1-APEX2 stress-granule hits 
(Markmiller et al. 2018). Overlapping hits are also represented as blue dots in (D).  
(G) Predicted structural analysis of ANXA11 revealed four C-terminal calcium-binding 
annexin repeats (blue), and a disordered N-terminal region. 
 
H-J. Recombinant ANXA11 undergoes liquid-liquid phase separation in vitro. 
(H) PrDOS analysis of ANXA11 predicted a high likelihood of disorder of aa 1-185.  
(I) Full length ANXA11 formed spherical, fusing liquid droplets at concentrations above 
50μM (upper panel). Phase separation of ANXA11 was facilitated by 10% dextran, with 
phase separation occurring at lower ANXA11 concentrations (≥ 10μM). Scale bar: 5 μm. 
See also Fig S2 A. 
(J) The disordered N-terminus (aa 1-185, upper panel) of ANXA11 but not C-terminus 
(aa 186-502, lower panel) underwent liquid-liquid phase separation. Scale bar: 5 μm. 
 
K-Q. Recombinant ANXA11 interacts with negatively charged lysosome-
associated phospholipids. 
(K) Surface maps of predicted ANXA11 structure +/– Ca2+ showing increased positive 
surface charge (blue) in the presence of Ca2+. Top panel shows orientation of ANXA11 
and location of Ca2+ ions (green). 
(L) Protein lipid overlay assay of recombinant ANXA11-GST protein with membrane 
lipids. Recombinant ANXA11-GST protein was incubated with a membrane lipid strip +/– 
Ca2+, followed by anti-GST immunoblotting. Arrowheads indicate enriched lipid binding. 
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Red line highlighted the correlated phospholipid species. 
(M) Liposome flotation assay of recombinant ANXA11 with liposomes containing 
PI(3,5)P2 in the absence or presence of Ca2+. Liposomes with associated proteins 
floated to the top layer following ultra-centrifugation (schematic). ANXA11 in the top (T), 
middle (M) and bottom (B) fractions was detected via anti-ANXA11 western blot.  
(N) Quantification ANXA11 enrichment in the top liposome fraction in Figure 2M. n = 3, 
error bars = SEM.  
(O) Microscopy analysis of calcium-dependent recruitment of recombinant ANXA11 
protein to fluorescent PI3P-containing liposomes. Representative images showed 
ANXA11 binding to PI3P-containing liposomes at the indicated calcium concentrations. 
Scale bar, 5μm. 
(P) Microfluidic device design for diffusional sizing assay of calcium-dependent ANXA11 
binding to liposomes. Inset indicates detection area. The fluorescent intensity along the 
channel indicates different diffusion times of ANXA11. Scale bar, 200 μm. 
(Q) Microfluidic diffusional sizing assay to assess changes in molecular radius of 
ANXA11 upon Ca2+-dependent binding to liposomes (top panel). Bottom panel: 
Quantification of hydrodynamic radius of ANXA11 when binding to liposomes with (dots) 
and without (diamonds) PI3P versus Ca2+ concentration. Data were fitted with a Hill 
binding model.  
 
Figure 3. ANXA11 interacts with both RNA granules and lysosomes in living cells. 
A-D. ANXA11 interact with RNA granules in cells 
(A) ANXA11-mEmerald redistributes from the cytoplasm into dispersed puncta 
immediately following heat shock (43oC) in U2OS cells. Scale bar: 20 μm. See also Fig 
S3 A. 
(B) Heat shock induced ANXA11-mEmerald puncta in U2OS cells are motile and 
undergo fusion (upper panel), and recover rapidly after photobleaching (i.e., 
FRAP)(bottom panel). Scale bar: 1 μm. See also Fig S3 B. 
(C) Quantification of FRAP experiment in (B), n=23. Error bars = SEM. See also FigS3 
C. 
(D) Immunostaining of mEmerald-tagged ANXA11 with RNA granule markers (Cy3-Oligo 
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dT(30), anti-G3BP1) before, during and 4 hours after heat shock (HS) in U2OS cells. 
Line scans show the related intensity profiles of ANXA11 with mRNA (Cy3 Oligo-dT) and 
with G3BP1. Scale bar: 30 μm. See also Fig S3D. 
(E) Immunostaining of mEmerald-tagged ANXA11 full-length, N-terminal or C-terminal 
domain and G3BP1 following 30 minutes of heat shock (43oC) in U2OS cells. Line 
scans show the related intensity profiles of ANXA11 with G3BP1. Scale bar: 30 μm. 
Right panels show the quantification of ANXA11 tructation area overlap with 
G3BP1(relative to ANXA11 area). One-way ANOVA, *p < 0.05, ****p < 0.0001, n=10. 
Error bars = SEM. Scale bar: 30 μm. See also Fig S3 E, F. 
 
F-K. ANXA11 puncta interact with lysosomes in cells 
(F) Panel 1: Live cell imaging of U2OS cells expressing ANXA11-mEmerald and 
LAMP1-HaloTag following heat shock at 43oC in U2OS cells. Panels 2-4: Enlarged 
areas of panel 1, with arrows pointing to ANXA11/lysosome contact sites (Scale bar: 1 
μm). See also Fig S3 H. 
(G) Rat cortical neurons expressing LAMP1-HaloTag and ANXA11-mEmerald imaged 
after heat shock. ANXA11 puncta co-localized with lysosomes in different neuronal 
regions: soma (1,2), dendrite (3,4) and axon (5). Arrows point to contact sites between 
lysosomes) and ANXA11 puncta. Scale bar: 5 μm 
(H) Live imaging of rat cortical neuron axons expressing LAMP1-HaloTag and ANXA11-
mEmerald. The corresponding kymograph shows ANXA11 puncta (green) either co-
trafficking or co-localizing with lysosomes (magenta). Scale bar: 5 μm. See also Fig S3 
G. 
(I) Immunostaining of mEmerald-tagged ANXA11 full-length, N-terminal or C-terminal 
domain with LAMP1-positive lysosomes in U2OS cells following 30 minutes of heat 
shock (43oC). Line scans show related intensity profiles of ANXA11 and LAMP1. Scale 
bar: 30 μm. Far right panel shows the quantification of ANXA11 trucations and LAMP1 
co-localization (relative to ANXA11 area). One-way ANOVA, *p < 0.05, ****p < 0.0001, 
n=10. Error bars = SEM. Scale bar: 30 μm. 
(J) FLIM-FRET analysis of the interaction between ANXA11 and lysosomes and its 
regulation by lysosomal Ca2+ and PI(3,5)P2. Human i3Neurons were transduced with 
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ANXA11-mCerulean3 (FRET donor) and LAMP-YFP (FRET acceptor). FLIM-FRET 
images were acquired for the same neurons before and after treatment with ML-SA1, 
BAPTA-AM or YM201636, and the lifetime of the ANXA11-mCerulean3 signal was 
determined. Left vertical panels show intensity images of LAMP1-YFP with the various 
treatments. Middle and right panels show ANAX11-mCeurlean3 lifetimes before and 
after drug treatment. 
(K) Quantification of FLIM-FRET lifetime measurements from (H). N=31 (NT), 24 (ML-
SA1), 20 (BAPTA-AM), 24 (YM201636). One-way ANOVA, *p < 0.05. Error bars = SEM. 
 
Figure 4. Effects of ALS-associated ANXA11 mutations on RNA granule 
interactions 
(A) U2OS cells expressing mEmerald-tagged ANXA11 (wt, D40G, R235Q or R346C) 
were heat shocked (43oC) for 30 minutes. A single ANXA11-positive puncta in each of 
the different transfected cells was photobleached and recovery of fluorescence was 
monitored by time-lapse imaging. Scale bar: 1 μm.  
(B) Quantification of the FRAP experiments in (A), n=21. Error bars = SEM. 
(C) Phase partitioning characteristics of ANXA11 ALS-associated mutants in vitro. 
Purified wt, D40G, R346C ANXA11 was temperature transitioned between 4oC and 
25oC through multiple cycles. ANXA11(p.D40G) formed both large spherical droplets 
and smaller, non-fusing gelled condensates, with the condensates unable to reform 
after one round of temperature shift (middle panel). ANXA11(p.R346C) formed 
irregularly-shaped solid and spiculated gelled condensates with few, if any, liquid 
droplets capable of disassembly/reassembly during temperature shifts (bottom panel). 
Scale bar: 5 μm. 
(D) U2OS cells expressing similar level of Opto-mCherry (CRY2olig-mCherry), Opto-
ANXA11 or Opto-ANXA11 ALS-associated mutant were exposed to 0.2% 488nm light to 
initiate oligomerization. Scale bar: 30 μm. See also Fig S4 B. 
(E) Quantification of integrated fluorescence intensity of Opto-labeled proteins in (D) 
during 300 seconds of 488 nm light activation, n=20. Error bars = SEM. See also Fig S4 
C. 
(F) Quantification of the number of Opto-labeled puncta present 30 minutes after the 
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488 nm light was turned off. n=17-19. One-way ANOVA, ns, not significant. ****p < 
0.0001. Error bars= SEM. 
(G) Immunostaining of mEmerald-tagged wild-type and mutant ANXA11 with G3BP1 
and mRNA labeled by Oligo-dT in U2OS cells following 30 minutes of heat shock. Co-
localization of ANXA11 with individual RNA granules is plotted in the line scans to the 
right. Scale bar: 30 μm. See also Figure S4 D. 
(H) Quantification of percentage of area of ANXA11 structures co-localizing with 
G3BP1-labeled RNA granules in (G). n=28-31. One-way ANOVA, ns, not significant. 
****p < 0.0001. Error bars = SEM. 
 
Figure 5. ALS-associated mutations in ANXA11 disrupt its interactions with 
lysosomes 
(A) Live cell imaging of Opto-mCherry, wild-type Opto-ANXA11, or mutant Opto-
ANXA11 with LAMP1-HaloTag in U2OS cells before and after oligomerization induced 
by exposure to 488nm light. Scale bar: 2 μm. See also Fig S5A. 
(B) Quantification of percentage of light-activated Opto-mcherry (CRY2olig-mCherry), 
wild-type Opto-ANXA11, or mutant Opto-ANXA11 clusters co-localizing with lysosomes 
at 300s post-488 nm light exposure from (A). n=26-30. One-way ANOVA, ns, not 
significant. ****p < 0.0001. Error bars = SEM. See also Fig S5B. 
(C) Extent of co-localization of wild-type or mutant ANXA11 with lysosomes. U2OS cells 
expressing LAMP1-HaloTag, wild-type ANXA11-mEmerald or mutant ANXA11-
mEmerald were imaged 30 minutes after heat shock (43oC). Scale bar: 2 μm. 
(D) Percentage of fluorescence associated with wild-type ANXA11 or mutant ANXA11 
that co-localized with lysosomes from (C). n= 22-40. One-way ANOVA, ns, not 
significant. ****p < 0.0001. *p < 0.05. Error bars = SEM. 
(E) Extent of co-trafficking of wild-type or mutant ANXA11 with lysosomes in axons. 
Axons of rat cortical neurons expressing LAMP1-HaloTag and wild-type or mutant 
ANXA11-mEmerald were imaged for 30 seconds. Kymographs show WT and p.D40G 
ANXA11 co-traffic with lysosomes (see arrows) while p.R235Q and p.R346C disrupt 
ANXA11 co-trafficking with lysosomes. Scale bar: 10 μm.  
(F) Number of puncta containing WT or mutant ANXA11 that co-trafficked with 
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lysosomes as a function of total lysosome number from (E). n= 21-30. One-way 
ANOVA, ns, not significant. **p < 0.01. *p < 0.05. Error bars = SEM. 
 
Figure 6. ANXA11 acts as an adaptor between RNA granules and lysosomes 
 (A) Time-lapse imaging of U2OS cells expressing LAMP1-HaloTag, Opto-ANXA11 and 
mEmerald-G3BP1 after 488nm light exposure to induce Opto-ANXA11 oligomerization. 
U2OS cells were exposed to heat shock (43 oC) for 15 minutes prior to light activation to 
form visible G3BP1 stress granules. Stress granules (green) associate with LAMP1-
labeled lysosomes (white) at sites where ANXA11 puncta (red) are localized. Scale bar: 
1 μm. See also Fig S6 A, Video 3. 
(B) Live cell confocal imaging of U2OS expressing LAMP1-HaloTag, ANXA11-mEmerald 
and mCherry-G3BP1 following 30 minutes of heat shock (43oC). Quantification of the 
intensity profiles of the different probes across midline of stress granules (dotted line) is 
shown to right n=6, Error bars = SEM. Scale bar: 1μm.  
(C) Schematic of in vitro RNA granule liposome reconstitution assay. 
(D) Stress granule cores were purified from cultured cells, and incubated with PI3P 
containing liposomes +/– recombinant ANXA11 +/– Ca2+. Upper panel: + ANXA11 only, 
Middle panel: + Ca2+only, Bottom panel: + both ANXA11 and Ca2+. Scale bar=10 μm. 
(E) Quantification of mean intensity of stress granule binding to PI3P containing 
liposomes in (D). n>300, One-way ANOVA, ***p < 0.001. Error bars = SEM. 
(F) Co-localization of ANXA11, lysosomes, and RNA granules in axons. Rat cortical 
neurons were transduced with LAMP1-HaloTag to label lysosomes, ANXA11-mEmerald, 
and mCherry-G3BP1 to label RNA granules. Arrows indicate areas of ANXA11, 
lysosome and RNA granule co-localization. Scale bar: 5 μm. See also Fig S7 A, Video 
4, 5. 
(G) ANXA11 knockdown perturbs mRNA/lysosome co-trafficking in axons. Kymographs 
of mRNA (actin-24xMBS/ MCP-NLS-2xEGFP) and lysosome (LAMP1-HaloTag) 
trafficking in axons is shown. Rat neurons expressed control or ANXA11-targeting 
shRNAs. Scale bar: 5 μm. 
(H) Quantification of (G). n=22-36, t-test, ns, not significant.  **p < 0.01. Error bars = 
SEM. 
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(I) smFISH of beta-actin in growth cones from neuron expressing control shRNA (left 
panel) or ANXA11 shRNA (right panel). Black colored spots represent the signal from 
beta-actin smFISH probes, red signal represents membrane stain of growth cones. 
Scale bar: 1 μm. 
(J) Quantification of average number of beta-actin mRNA molecules in (I). N=44-96, t-
test, ns, not significant. **p < 0.01. Error bars = SEM. 
 
Figure 7. Effects of ALS-associated ANXA11 mutations on axonal RNA 
granule/lysosome hitchhiking 
(A) Kymographs of mRNA (actin-24xMBS/ MCP-NLS-2xEGFP ) and lysosome (LAMP1-
HaloTag) trafficking in rat neuron axons expressing wild-type or R235Q mutant ANXA11. 
Arrows point to examples of mRNA co-trafficking with lysosomes. Scale bar: 10 μm. 
(B) Quantification of (A). n=14-36. One-way ANOVA. *p < 0.05, **p < 0.01.  Error bars = 
SEM. 
(C) smFISH of beta-actin in growth cones from rat neurons expressing wild-type or 
mutant ANXA11. Black colored spots represent the signal from beta-actin smFISH 
probes, red signal represents membrane stain of growth cones. Scale bar: 1 μm. 
(D) Quantification of (C). N= 64-128. One-way ANOVA. ****p < 0.0001,  Error bars = 
SEM. 
(E) Lysosome trafficking in live zebrafish embryo ganglion axons. Lysosomes were 
labeled with LAMP1-TagBFP2 in zebrafish pLL ganglions; insets show ganglion (left) 
and axon tips (right). Time-lapse imaging reveals bi-directional lysosomal trafficking in 
these axons (bottom middle panels). 
(F) Imaging of live zebrafish neurons reveals bidirectional co-trafficking of CAPRIN1-
positive RNA granules with lysosomes in axons. Yellow arrows point to anterograde co-
trafficking of LAMP1 (green) and CAPRIN1 (magenta); white arrows point to retrograde 
co-trafficking of LAMP1 (green) and CAPRIN1 (magenta). Corresponding kymograph 
shown below. See also Supplemental Video 6. 
(G) Imaging of live zebrafish neurons expressing ANXA11 and CAPRIN1 reveals co-
trafficking of ANXA11-labeled structures (green) with CAPRIN1 (magenta) in axons. 
Corresponding kymograph shown below. See also Supplemental Video 7. 
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(H) Effect of ANXA11 ALS-associated mutations on trafficking of CAPRIN1-labeled RNA 
granules in zebrafish axons. CAPRIN1 and wild-type or mutant ANXA11 were 
expressed in zebrafish ganglion. Anterograde or retrograde trafficking of CAPRIN1 
vesicles per μm along the axon length were quantified in each group. n = 9-18. Two-way 
ANOVA with Tukey post-hoc analysis, ns, not significant. *p < 0.05. Error bars = SEM. 
See also Fig S7 E-G.  
 
SUPPLEMENTAL FIGURE LEGENDS 
Supplemental Figure 1. RNA granules hitchhike on motile lysosomes in 
mammalian cells. Related to Figure 1. 
(A) Quantification of the percentage of RNA granules in contact with different organelles 
from Fig 1A. (n=7). 
(B) Contacting RNA granules and lysosomes are frequently in close association with 
ER. U20S cells were transfected with LAMP1-HaloTag, mEmerald-SEC61 and low 
levels of mCherry-G3BP1 for 24hrs. Cells were imaged live for 30 minutes after heat 
shock (43oC). Arrows point to areas where co-localized LAMP1 (white)- and G3BP1 
(red)- labeled structures are in close association with Sec61-labeled ER (green). Scale 
bar: 1μm. 
(C) Quantification of velocity of G3BP1 labeled RNA granule co-localized or not co-
localized with lysosomes, n= 455 (number of granules, not co-localized), 396 (number of 
granules, co-localized), t-test, ***p < 0.001. Error bars = SEM. 
(D) Percentage of G3BP1 labeled RNA granule co-localized or not co-localized with 
lysosomes with displacement over 10μm, n=7 (number of cells), t-test, **p < 0.01. Error 
bars = SEM. 
(E) Percentage of G3BP1 labeled RNA granules treated or not treated with nocodazole 
with displacement over 10μm, n=4, t-test, *p < 0.05. Error bars = SEM. 
(F) Time-lapse image sequence showing an RNA granule co-trafficking with a lysosome 
along a microtubule. U2OS cells were transfected with LAMP1-HaloTag, Ensconsin-
GFP and low amounts of mCherry-G3BP1 for 24hrs. Images were acquired immediately 
after heat shock at 43oC. Scale bar: 1μm. 
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(G) Quantification of LAMP1 labeled lysosomes co-localizing with G3BP1 labeled RNA 
granules (relative to number of lysosome), n=20 (number of cells). 
(H) Kymograph of mEmerald tag and lysosomes in axons. Rat cortical neurons were 
transduced with LAMP1-HaloTag to label lysosomes and PGK promoter driven 
mEmerald tag. Time-lapse images of axons were acquired at 100ms/frame for 30 
seconds. Scale bar: 5 μm. 
(I) Kymographs illustrating co-trafficking and stationary interaction patterns of lysosomes 
with RNA granules. Rat cortical neurons were transduced with LAMP1-HaloTag to label 
lysosomes and actin-24xMBS/MCP-NLS-2xEGFP to label actin mRNA. Upper panel 
shows co-trafficking of lysosomes and mRNA, and bottom panel shows lysosomes and 
mRNA associating in a relatively stationary manner. Scale bar: 5 μm. 
(J) Kymograph of CAPRIN1-labeled RNA granules co-trafficking with lysosomes in 
axons. 
Rat cortical neurons were transduced with LAMP1-HaloTag to label lysosomes and 
mEmerald-CAPRIN1 to label RNA granules. Time-lapse images of axons were acquired 
at 100ms/frame for 30 seconds. Arrows point to lysosomes co-trafficking with CAPRIN1-
labeled structures. p50/p150Glued, doxycycline-inducible expression of a p50 dynactin 
subunit and the CC1 domain of the p150 glued subunit of dynactin. Scale bar: 5 μm. 
(K) Kymograph of TDP43-labeled RNA granules co-trafficking with lysosomes in axons.  
Rat cortical neurons were transduced with LAMP1-HaloTag to label lysosomes and 
mEmerald-TDP43 to label RNA granules. Time-lapse images of axons were acquired at 
100ms/frame for 30 seconds. Arrow points to a lysosome co-trafficking with a TDP43-
labeled structure. Dox, doxycycline-inducible expression of a p50 dynactin subunit and 
the CC1 domain of the p150 glued subunit of dynactin. Scale bar: 5 μm. 
(L) Quantification of frequency of G3BP1, actin-MS2, CAPRIN1, TDP43 labeled RNA 
granule and mEmerald tag in axons, n=22(mEmerald), 19(G3BP1), 35(actin-MS2), 
21(caprin1), 35(TDP43). 
(M) Quantification of LAMP1 labeled lysosomes co-localizing or co-trafficking with 
G3BP1, actin-MS2, CAPRIN1, TDP43 labeled RNA granules and mEmerald tag 
(relative to number of lysosomes) in axons, n=22(mEmerald), 19(G3BP1), 36(actin-
MS2), 25(CAPRIN1), 41(TDP43). 
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(N) Quantification of LAMP1-labeled lysosomes co-localizing or co-trafficking with 
G3BP1, actin-MS2 (relative to number of lysosomes), with or without doxycycline-
inducible expression of a p50 dynactin subunit and the CC1 domain of the p150 glued 
subunit of dynactin. N=35(G3BP1,-), 35(G3BP1, p50/p150Glued), 36(actin-MS2, -), 
30(actin-MS2, p50/p150Glued). T-test, **p < 0.01, *p < 0.05, ns, not significant. Error 
bars = SEM. 
 
Supplemental Figure 2. Recombinant ANXA11 undergoes liquid-liquid phase 
separation in vitro. Related to Figure 2. 
A. Purified ANXA11 protein formed biological condensates. 
Full length wild type ANXA11 formed spherical, fusing liquid droplets at ANXA11 
concentrations at 10μM facilitated by 10% dextran. Inset shows a fusion event between 
two phase separated liquid droplets.  
 
Supplemental Figure 3. ANXA11 exhibits phase condensate properties and 
interacts with both RNA granules and lysosomes in living cells. Related to Figure 
3. 
(A) ANXA11’s amino acid sequence 1-185 was tagged with mEmerald and expressed in 
U2OS cells. Small ANXA11 positive puncta appeared in cells that had not been heat 
shocked.  
(B) Live cell imaging of puncta from (A) reveal these structures are motile and undergo 
fusion (upper panel). Upon photobleaching, ANXA11 fluorescence within the puncta 
quickly returned from free cytoplasmic pools (bottom panel). Scale bar: 1 μm. 
(C) Quantification of the FRAP experiment in (B), n=7. 
(D) Co-localization of ANXA11 puncta with RNA granule markers before, during and after 
heat shock (HS). U2OS cells under normal culture conditions (before HS), under heat 
shock (HS) or 4 hours after heat shock (after HS) were fixed, hybridized with Cy3-Oligo 
dT(30) followed by immunostaining with antibody against TDP43. Linescans show the 
related intensity profiles of ANXA11 with mRNA (Cy3 Oligo-dT) and with TDP43. Scale 
bar: 30 μm. 
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(E) Co-localization of ANXA11 full-length, N-terminal or C-terminal domain with RNA 
granules. U2OS cells were fixed after 30 minutes of heat shock (43oC), followed by 
immunostaining with antibody against TDP43. Line scans show the related intensity 
profiles of ANXA11 with TDP43. Scale bar: 30 μm. One-way ANOVA, ****p < 0.0001, 
n=20 (FL), 11(NTD), 19(CTD), Error bars=SEM.  
(F) Co-localization of ANXA11 full-length, N-terminal or C-terminal domain with RNA 
granule. U2OS cells were fixed after 30 minutes of heat shock (43oC), followed by 
hybridizing with Cy3-Oligo dT(30). Linescans show the related intensity profiles of 
ANXA11 with TDP43. Scale bar: 30 μm. One-way ANOVA, ****p < 0.0001, n=30 (FL), 
30(NTD), 27(CTD), Error bars=SEM.  
(G) Rat cortical neurons were transduced with ANXA11-mEmerald. A single labeled 
ANXA11 puncta was photobleached, then the recovery of fluorescence into the bleached 
region-of-interest was examined over time. Scale bar: 2 μm. 
(H) Time-lapse imaging showing the interaction of ANXA11 puncta (red) with LAMP1-
labeled lysosomes (white) in U2OS cells after heat-shock. Scale bar: 1 μm. 
(I) Quantification of LAMP1 labeled lysosomes co-localizing with ANXA11(relative to 
number of lysosomes) in U2OS or rat neuron. N=25(U2OS), 10(neuron). 
 
Supplemental Figure 4. ALS-associated mutations in ANXA11 disrupt RNA 
granule interactions. Related to Figure 4. 
(A) A schematic map of ANXA11 protein with the position of ALS-associated mutants. 
(B) Quantification show the temporal evolution of the integrated fluorescence intensity 
from the expressed Opto-mCherry, ANXA11 full-length, NTD or CTD proteins during 300 
seconds of light activation, n=11 (Opto-mCherry), 17 (ANXA11 full-length), 20(ANXA11 
NTD), 20(ANXA11 CTD). Error bars = SEM. 
(C) U2OS were transfected with Opto-mCherry (CRY2olig-mcherry), Opto-ANXA11,  
Opto-ANXA11 NTD or Opto-ANXA11 CTD for 24hrs. Cells with similar Opto-ANXA11 
expression levels were exposed to 0.2% 488nm light to initiate oligomerization. Scale 
bar: 30 μm. 
(D) Co-localization of ANXA11 or ANXA11 ALS-associated mutants with TDP43 and 
mRNA labeled by Oligo-dT. U2OS cells expressing mEmerald labeled ANXA11 or 
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ANXA11 ALS-associated mutants were heat shocked for 30 mins, fixed, and then 
hybridized with Cy3-Oligo dT(30) and immunostained with antibodies against TDP43 to 
label RNA granules. The extent of co-localization of ANXA11 or the ALS-associated 
mutants with the RNA granules is plotted in the line-scans to the right.  
(E) Quantification of percentage of area of ANXA11 structures co-localizing with TDP43-
labeled RNA granules in (D). One-way ANOVA, ns, not significant. ****p < 0.0001. Error 
bars = SEM. N=12 (WT), 7 (D40G), 6 (R235Q), 7(R346C). 
(F) Co-localization of ANXA11 or ANXA11 ALS-associated mutants with RNA granules 
labeled by TDP43 and mRNA labeled by Oligo-dT after heat shock (HS). U2OS were 
heat shocked for 30 mins and then moved to 37oC for 4 hrs to allow recovery. The cells 
were then fixed, hybridized with Cy3-Oligo dT(30) followed by immunostaining with 
antibodies against TDP43 to label RNA granules. Linescan analysis show the related 
intensity profiles of ANXA11 or ALS-associated mutations with mRNA (Cy3 Oligo-dT) 
and TDP43. Scale bar: 30 μm. 
(G) Co-localization of ANXA11 or ALS-associated ANXA11 mutants with RNA granules 
labeled by G3BP1 and mRNA (right panel) after heat shock (HS). U2OS were heat 
shocked for 30 mins and then moved to 37oC for 4 hrs to allow recovery. The cells were 
then fixed, hybridized with Cy3-Oligo dT(30) followed by immunostaining with antibodies 
against G3BP1 (right panel) to label RNA granules. Linescan analysis show the related 
intensity profiles of ANXA11or ALS-associated ANXA11 mutants with mRNA (Cy3 Oligo-
dT) and G3BP1. Scale bar: 30 μm. 
(H) U2OS cells expressing mCherry-G3BP1 to label RNA granules were co-transfected 
with ANXA11-mEmerald, ANXA11(D40G)-mEmerald, ANXA11(R235Q)-mEmerald or 
ANXA11(R346C)-mEmerald for 24 hrs. Cells were heat shocked (43oC) for 30 min, A 
single G3BP1-positive puncta in each of the different transfected cells was 
photobleached and recovery of fluorescence into the puncta was monitored by time-
lapse imaging. Scale bar: 1 μm.  
(I) Quantification of H. N=7(WT), 9(D40G), 8(R235Q), 7(R346C). Error Bars=SEM. 
 
Supplemental Figure 5. ALS-associated mutations in ANXA11 disrupt its 
interactions with lysosomes, related to Figure 5. 
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(A) Co-localization of light-activated opto-ANXA11 or ANXA11 N-terminal domain or C-
terminal domain with lysosomes in cells. U2OS cells were co-transfected with LAMP1-
HaloTag, Opto-mcherry (CRY2olig-mcherry), Opto-ANXA11, Opto-ANXA11 NTD or 
Opto-ANXA11 CTD for 24 hrs. Cells with similar Opto-ANXA11 expression levels were 
exposed to 0.2% 488nm light to initiate oligomerization. Cells were imaged over 300 
seconds of light activation. Scale bar: 2 μm. 
(B) Percentages of light-activated Opto-mcherry (CRY2olig-mcherry), Opto-ANXA11 
Opto-ANXA11 NTD or Opto-ANXA11 CTD clusters co-localizing with lysosomes after 
300 seconds of light activation from the experiment in (A). n=14 (Opto-mcherry), 18 
(ANXA11 full-length), 21(ANXA11 NTD), 21(ANXA11 CTD). One-way ANOVA, ns, not 
significant. ****p < 0.0001. Error bars = SEM. 
(C) Frequency of LAMP1 labeled vesicles in axons expressed ANXA11 or ALS-
associated ANXA11 mutants. n=25(WT), 50(D40G), 15(R235Q), 22(R346C). One-way 
ANOVA, ns, not significant. Error bars = SEM. 
 
Supplemental Figure 6. ANXA11 acts as an adaptor between RNA granules and 
lysosomes. Related to Figure 6. 
(A) Additional example of a time-lapse imaging sequence of U2OS cells expressing 
LAMP1-HaloTag, Opto-ANXA11 and mEmerald-G3BP1 after 0.2% 488nm light 
activation to initiate Opto-ANXA11 oligomerization. U2OS cells were exposed to heat 
shock (43 oC) for 15 minutes prior to light activation. Here, G3BP1-labeled RNA 
granules (green) associate with ANXA11 puncta (red) in the cytoplasm before 
redistributing onto the surface of LAMP1-labeled lysosomes (white) as merged puncta. 
Scale bar: 1 μm. 
(B) Quantification of the percentage of RNA granules co-localizing with LAMP1 over 
300s with or without light activation in (A). N=11. Paired t-test, **, p<0.01. Error bars = 
SEM. 
(C) Percentage of co-localization between ANXA11 and LAMP1, G3BP1 and LAMP1, 
G3BP1 and ANXA11. N=20. Error bars = SEM. 
(D) Q-PCR shows relative ANXA11 mRNA level in control shRNA or ANXA11 shRNA 
transduced neurons. N=3. Error bars = SEM. 
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(E) Frequency of LAMP1-labeled vesicles in axons expressed control shRNA or 
ANXA11 shRNA. N=36(sh control), 35 (sh ANXA11), t-test, ns, not significant. Error bars 
= SEM. 
(F) Effect of ALS-associated ANXA11 mutants on RNA granule-lysosome association in 
heat shocked cells. U2OS cells were transfected with mEmerald tagged ANXA11 or 
ANXA11 ALS-related mutant constructs. Cells were heat shocked (43oC) for 30 minutes, 
fixed, followed by immunostaining with antibodies against G3BP1 and LAMP1 to 
examine the effects of ANXA11 mutants on RNA granule-lysosome contacts compared 
to those in WT ANXA11-mEmerald expressing cells. Arrows point to G3BP1-labeled 
RNA granule(megenta) contacting with lysosomes(red). Scale bar: 30 μm. 
(G) Percentage of G3BP1-labeled granules co-localized with LAMP1-labeled lysosomes 
in (E). n= 20 (WT), 25 (D40G), 28 (R235Q), 28 (R346C). One-way ANOVA, ns, not 
significant. ****p < 0.0001. Error bars = SEM. 
(H) U2OS cells were transfected with mEmerald tagged ANXA11 or ANXA11 ALS-
related mutant constructs. Cells were heat shock (43oC) for 30 minutes, fixed, 
hybridized with Cy3-Oligo dT(30) followed by immunostaining with antibodies against 
LAMP1 to examine the effects of ANXA11 mutants on RNA granule-lysosome contacts 
compared to that in WT ANXA11-mEmerald expressing cells. Graphs on the right 
represent intensity profiles across the dotted line, revealing the ANXA11 mutants 
R235Q and R346C show decreased colocalization with RNA granules and lysosomes 
and affected RNA granule-lysosome contact. Scale bar: 1μm. 
 
Supplemental Figure 7. ALS-associated mutations in ANXA11 disrupt RNA 
granule hitchhiking on lysosomes in axons from rat cortical neurons and 
zebrafish neurons. Related to Figure 7. 
(A) Kymographs showing RNA granule protein and mRNA co-transport on the same 
lysosomes in axons. Rat cortical neurons were transduced with LAMP1-HaloTag to label 
lysosomes (red), and mCherry-G3BP1 to label RNA granules (green), and actin-
24xMBS/ MCP-NLS-2xEGFP(blue). Time-lapse movies of axons were then acquired at 
100ms/frame for 30 seconds and displayed in kymograph format. Arrows point to a 
example of both G3BP1 and mRNA co-trafficking with lysosomes. Scale bar: 5 μm. 
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(B) Kymographs showing the effect of ALS-associated ANXA11 mutants on RNA co-
trafficking with lysosomes in rat neuron axons. Rat cortical neurons were transduced 
with LAMP1-HaloTag to label lysosomes (red), actin-24xMBS/ MCP-NLS-2xEGFP 
(green) and ANXA11 (upper panel) or ANXA11 (D40G) (bottom panel). Time-lapse 
movies of axons were then acquired at 100ms/frame for 30 seconds and displayed in 
kymograph format. Arrows point to an example of RNA granule co-trafficking with 
lysosomes. Scale bar: 5 μm. Quantification of RNA granule co-localization or co-
trafficking with lysosomes in axons expressing either ANXA11 or ANXA11 p. D40G 
mutation (relative to lysosome number). n=36 (WT), 12 (D40G). One-way ANOVA. ns, 
not significant. Error bars = SEM. 
(C) Quantification of growth cone area in axons expressing either ANXA11 or mutant 
ANXA11. N=61(WT), 56(D40G), 46(R235Q), 39(R346C). One-way ANOVA. **, p<0.01, 
ns, not significant. Error bars = SEM. 
(D) Quantification of growth cone area in axons expressing either ANXA11 or mutant 
ANXA11. N= 80(sh control), 54(sh ANXA11). unpaired t-test. ns, not significant. Error 
bars = SEM. 
(E) Quantification of vesicles triple labeled with CAPRIN1/LAMP1/ANXA11 over the total 
LAMP1 vesicles undergoing anterograde or retrograde transport in zebrafish axons. 
N=9-18. 
(F) Quantification of trafficking distance for CAPRIN1 vesicles in zebrafish axons. N=9-
18. Two-way ANOVA with Tukey post-hoc analysis, ns, not significant. *p < 0.05. Error 
bars = SEM. 
(G) Quantification of trafficking velocity for CAPRIN1 vesicles in zebrafish axons. 
N=9-18. Two-way ANOVA with Tukey post-hoc analysis. *p < 0.05. Error bars = SEM. 
 
STAR METHODS 
LEAD CONTACT AND MATERIALS AVAILABILITY 
Further information and requests for resources and reagents should be directed to the 
Lead Contact, Michael E. Ward (wardme@nih.gov). Plasmids generated in this study 
have been deposited to Addgene. iPSC lines will be distributed to interested parties 
upon request. 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS 
hiPSC culture 
The control male WTC11 human induced pluripotent stem cells (hiPSC) line was 
obtained from Coriell. We adhered to NIH Intramural Research Program policies 
regarding the registration and use of this iPSC line. Karyotyping was used to 
authenticate that the line had a normal male karyotype. HiPSCs were maintained under 
feeder-free conditions in a 37oC, 5% CO2 tissue culture incubator on tissue culture 
treated dishes coated with growth factor-reduced Matrigel (BD Biosciences) and fed 
every 1-2 days with Essential 8 medium (Thermo Fisher Scientific), as needed. 
Accutase (STEMCELL Technologies) was used to enzymatically dissociate hiPSCs into 
single cells, and 0.5mM EDTA was used for routine dissociation to maintain colony 
growth. To promote cell survival during passaging, cells were passaged with the p160-
Rho-associated coiled coil kinase (ROCK) inhibitor Y-27632 (10 M: Selleckchem) 
(Watanabe et. al., 2007). hiPSCs were frozen in 90% fetal bovine serum (HyClone) and 
10% DMSO (Sigma).  
Generation of Stable hiPSC Lines 
WTC11 hiPSCs with single-copy integration of a doxycycline-inducible NGN2 cassette 
at the AAVS1 locus (Fernandopulle et al, 2018) were singularized with Accutase, 
resuspended in PBS, and counted with a Countess automatic cell counter (Life 
Technologies). For plasmid transfections, 1.5 million hiPSCs were seeded onto one well 
of a 6-well dish in Essential 8 supplemented with Y-27632 (10 M). 2-5 hours later, 
Lipofectamine Stem (Thermo Fisher Scientific) was used to introduce the appropriate 
knockin vector (CLYBL-LAMP1-APEX2 or CLYBL-LAMP1-NES-APEX2) (1.8 g) and 
each CLYBL TALEN pair (0.6 g each). Cells were dissociated the next day onto a 
10cm dish and maintained for 1 week in Essential 8 medium (supplemented with 10 M 
Y-27632 for the first 2 days). Single fluorescent cells were then isolated and seeded in 
individual wells of a 96-well dish by FACS on a Sony SH800S Cell Sorter. These cells 
were maintained in Essential 8 Flex medium (Thermo Fisher Scientific) supplemented 
with RevitaCell (Thermo Fisher Scientific). After 1-2 weeks, clones were dissociated 
with Accutase and seeded into 6-well dishes in Essential 8 medium supplemented with 
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Y-27632. Genomic DNA was isolated with a Quick-DNA Microprep Kit (Zymo Research) 
and single-copy CLYBL integration was confirmed with PCR. PCR positive clones were 
subsequently checked for genomic abnormalities with karyotyping. 
Inducible System for Neuron Differentiation 
 Stable hiPSC lines was generated from the WTC11 genetic background with a 
doxycycline-inducible mNGN2 transgene at the AAVS1 locus. For differentiation, 25 
million hiPSCs were seeded onto a 15cm tissue culture dish in Neuronal Induction 
Medium (NIM), composed of DMEM/F12 medium (ThermoFisher Scientific), N-2 
supplement (ThermoFisher Scientific), Nonessential amino acids supplement (NEAA) 
(ThermoFisher Scientific), Gluta-MAX supplement (ThermoFisher Scientific), Y-27632 
(10 M), and doxycycline (2 g/ml, Sigma). Cells were maintained on NIM with daily full 
medium changes for 3 days.  
hiPSC-derived Neuron Culture 
 After the 3-day differentiation period, cells were dissociated with Accutase from 
the 15-cm dish and seeded onto final experimental plates coated with poly-L-ornithine 
(0.1 mg/ml). Cells were seeded and maintained in Cortical Neuron Culture Media, 
composed of BrainPhys Neuronal Medium (STEMCELL Technologies), B-27 
supplement (ThermoFisher Scientific), brain-derived neurotrophic factor (10 ng/ml), 
neurotrophin-3 (10 ng/ml), and mouse laminin (1 g/ml). Half-media changes were 
conducted every 3 days for the lifetime of the culture.  
U2OS cell culture 
The U2OS cell line used in these studies was the human osteosarcoma cell line, 
obtained directly from ATCC (HTB96). Cells were authenticated by morphological 
assessment under microscopy. Cells were grown in a 37oC, 5% CO2 tissue culture 
incubator on tissue culture treated dishes in DMEM + 10% FCS and passaged with 
Trypsin EDTA. 
Primary Cortical Neuron Culture 
        Cortices were dissected from E17 Sprague-Dawley rat embryos. Rat maintenance 
and care followed policies advocated by NRC and PHS publications, and approved by 
Institutional Animal Care and Use Committee (IACUC), Janelia Research Campus. 
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Tissue were digested with papain and gently triturated and filtered through 70 micron 
strainer. Neurons were plated in poly-L-ornithine coated dishes and cultured in 
Nbactive4 medium at 37o C, indicated virus were transduced at DIV 10-14 and imaged 
at DIV 17-21. 
Zebrafish husbandry 
Adult *AB were maintained at 28.5oC and spawned according to standard protocols 
(Kimmel et al., 1995). Embryos were derived from natural matings or in vitro fertilization, 
raised in embryo media, and developmentally staged using previously established 
methods (Westerfield, 2000). All in vivo experimental protocols were approved by the 
National Institute of Child Health and Human Development Animal Care and Use 
Committee (ASP18.008). 
 
METHOD DETAILS 
Plasmids and Cloning 
 All plasmids generated in this study have been deposited to Addgene. Plasmids 
for generating stable iPSC lines (e.g. APEX2 constructs) were designed with 1 kb left 
and right homology arms against the CLYBL (citrate lyase subunit beta-like protein, 
Uniprot ID: Q8N0X4) locus. This locus was chosen to permit stable expression in both 
the iPSC and neuron stages. Plasmids were generated with PCR and recombinase-
based cloning (In-Fusion® by Clontech or NEBuilder by NEB). Plasmids for virus 
transduction in neurons (e.g. ANXA11-mEmerald, ANXA11-mCerulean3 LAMP1-
HaloTag, LAMP1-YFP, mcherry-G3bp1,mEmerald-G3bp1, mcherry-TDP43, mEmerald-
TDP43, mEmerald-caprin1) were generated with the pLEX lentiviral vector (Thermo 
Scientific) and ligation-based cloning. Actin-24xMBS, MCP-NLS-HaloTag and MCP-
NLS-2xEGFP plasmids were kindly provided by Dr. Young Yoon from Dr. Robert H. 
Singer lab. Opto-ANXA11 plasmids were made by insertion of CRY2olig-mcherry on the 
N-terminal of ANXA11 plasmids by Gibson cloning. ANXA11 shRNA expression 
cassettes were made by oligo annealing and ligation into pLKO.1 vector. 
Antibodies 
 Mouse monoclonal anti-Lamp1 antibody (H4A3, Developmental Studies 
Hybridoma Bank) was used extensively for western blot (WB) and immunofluorescence 
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(IF) studies, and mouse monoclonal M2 anti-Flag antibody (F3165, Millipore Sigma) 
was used to detect Lamp1-APEX expression via IF. GST Tag monoclonal antibody (8-
326, ThermoFisher) was used to detect ANXA11-GST in lipid strip assay. Polyclonal 
rabbit anti-ANXA11 (HPA027545) was used for WB in lysosomal isolation experiments, 
liposome floatation as well as for protein localization via IF. Polyclonal rabbit anti-TDP43 
(10782-AP, Proteintech) and anti-G3BP1 (13057-2-AP, Proteintech) were used to detect 
stress granule formation via IF, and anti-G3BP1 was also used for stress granule 
isolation (IP) and WB.  
APEX proteomics 
 hiPSC-derived neurons were grown to a density of 10 million cells per 10cm dish. 
4 biological replicates of each experimental condition were used. To provide a substrate 
for the APEX enzyme, cells were fed with 500uM phenol-biotin (CAS 41994-02-9, 
Adipogen) and incubated at 37C for 30 minutes prior to enzyme stimulation. To 
stimulate APEX2, cells were treated with 1mM hydrogen peroxide and incubated at 37C 
for 1 minute. The reaction was terminated by aspirating the growth medium and adding 
4mL of ice-cold quench buffer (10mM sodium azide, 10mM sodium ascorbate, 5mM 
TROLOX in PBS) 3 times before lysing the cells with 600uL of Lysis buffer (50mM Tris-
Cl pH 7.4, 500mM NaCl, 0.2% SDS, 1mM DTT, 10mM sodium azide, 10mM sodium 
ascorbate, 5mM TROLOX, cOmplete mini protease inhibitor tablets, in MS-grade H2O). 
Cells were transferred to 4C room and incubated on a nutator until all stimulations were 
finished. Cells were scraped into 1.5mL polystyrene microcentrifuge tubes and 
sonicated (QSonica Q800R2) for 14 minutes with alternating 1-minute on/30 seconds 
off cycles. Lysate was spun at 4C at max speed for 12 minutes, and the supernatant 
was diluted with one volume of 50mM Tris-HCl . Samples were dialyzed to remove 
excess biotin and detergents. Dialysis buffer composed as follows: 50mM Tris-Cl pH 
7.4, 250mM NaCl, 0.1% SDS, 1% Triton X-100 in H2O. Samples were loaded into 
SnakeSkin™ dialysis tubing (Thermo Fisher Scientific) and placed within a 2L dialysis 
chamber with a spin bar at 4C. Samples were dialyzed at 4C for 4 hours, with dialysis 
solution replaced every hour. After dialysis, the protein concentration was quantified 
using a Bio-Rad DCA assay, and a bead titration was carried out to determine the 
optimal volume of beads to use for complete pulldown of biotinylated proteins. We used 
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Streptavidin Sepharose High Performance (GE Healthcare Life Sciences) beads for 
Lamp1-APEX experiments, and Nanolink Streptavidin Magnetic beads (Solulink) for 
ANXA11-APEX experiments. After normalization of protein amount and determination of 
optimal bead volume for each sample, bead incubation occurred overnight with agitation 
at 4C. The next day, beads were washed with 4 sequential buffers (Buffer 1: 2% SDS; 
Buffer 2: 50mM Tris-HCl pH 7.4, 00mM NaCl, 0.1% deoxycholic acid, 1% Triton-X, 1mM 
EDTA; Buffer 3: 10mM Tris-HCl pH 7.4, 250mM NaCl, 0.5% deoxycholic acid, 0.5% NP-
40, 1mM EDTA; Buffer 4: 50mM Ammonium bicarbonate; all in ddH2O). Then, proteins 
were reduced (5mM TCEP, 30 minutes), alkylated (15mM iodoacetamide, 30 min), 
quenched (5mM DTT, 15 min), and digested on beads overnight for 14 hrs with 1ug of 
trypsin/LysC enzyme (Promega). The next morning, 0.5ug of trypsin/LysC was added 
and incubated for another 2 hours at 37C at 1200 rpm. Samples were separated from 
beads with either centrifugation or magnetic separation, the supernatant was acidified 
with 10% trifluoroacetic acid (TFA), and samples were desalted using C18 solid-phase 
extraction spin columns. After eluting samples in 50% acetonitrile (ACN)/0.1% TFA, they 
were dried down in a speedVac and then resuspended in 2% ACN/0.1% formic acid 
(FA) for subsequent LC-MS analysis. 
LC-MS analysis 
Peptide samples were analyzed on a Dionex UltiMate 3000 RSLCnano system 
coupled with a Thermo Scientific Q-Exactive HF mass spectrometer. Mobile phase A 
was 0.1% FA, 5% DMSO in H2O, and mobile phase B was 0.1% FA, 5% DMSO in ACN. 
Flow rate was 0.3 L/min. Peptide separation was achieved on a PepMap C18 column 
(2 M, 100Å, 75M25 cm) with a 120 min LC gradient. Top 15 data-dependent 
acquisition (DDA) was conducted, and the MS was scanned from m/z 350 to1500 at a 
resolving power (RP) of 120K. Parent masses were isolated (m/z 1.4 window) and 
fragmented with higher-energy collisional dissociation (HCD) with a normalized collision 
energy (NCE) of 27%. Dynamic exclusion time was 22.5 s. Automatic gain control 
(AGC) targets were 1 × 106 for MS and 2 × 105 for MS/MS acquisitions. Maximum 
injection times (maxIT) were 30 ms for MS and 35 ms for MS/MS. 
ANXA11 homology models 
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 The full-length sequence of human ANXA11 (SWISSPROT code P50995) was 
submitted to the iTasser web server on 05/23/18 to identify suitable templates for 
structural modeling. The predicted secondary structure and unfolded nature of the 
resultant structural models confirmed the assignment of the N-terminal domain 
(residues 1-199) as unstructured. Template structures with good coverage of the C-
terminal segment were all annexins, of which the candidate with the highest similarity 
was human annexin A4 (~57 % identical residues). Among the available structures of 
ANXA4, PDB code 2ZOC has the highest resolution (2.0 Å) and contains four resolved 
calcium ions. To construct models of ANXA11 C-terminal domain with and without bound 
calcium ions, we used the pairwise sequence alignment obtained from iTasser (which is 
gapless for residues 5-319 of 2ZOC to residues 192-505 of ANXA11). Models were built 
using Modeller 9v19, with and without calcium ions in the same positions as in the 
template. Distance restraints were included in Modeller to optimize the calcium-oxygen 
interaction distances in the calcium binding sites, using upper bounds extracted from 
the equivalent interaction distances in the template. In each case, 100 models were built 
and ranked according to their MolPDF scores, which provides an assessment of the 
extent to which the model satisfies the restraints. We filtered out models with MolPDF 
scores outside the standard deviation obtained over all 100 models (excluding 9 and 14 
models for the apo and holo, respectively). The remaining models were filtered to 
consider only the 20 % models with the highest ProQ2 scores (> 0.928). The ProQ2 
score of the template is 1.005, for reference. Finally, we identified two models with the 
fewest backbone dihedral angles in the disallowed region of the Ramachandran plot, 
using PROCHECK. These models have 96.9 % and 96.5 % residues, respectively in the 
allowed regions of the Ramachandran plot, compared to 93.8 % for the template.  
Continuum electrostatics calculations 
Electrostatic potential surfaces were computed as follows. Partial charges and atomic 
radii were obtained for the model coordinate files using the PDB2PQR server v2.1.1, 
with the CHARMM force field, which includes calcium parameters. Poisson-Boltzmann 
electrostatic potentials were computed using the APBS plugin within Pymol using 
default parameters.   
Expression and purification of ANXA11 
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Constructs encoding ANXA11 residues 1-505 and its mutants (D40G, R235Q, 
R346C) , Annexin LC (aa1-185) and CTF (aa186-505), were either cloned into pOPINS 
vector containing an N-terminal His-Sumo Tag and a ULP protease cleavage site or in 
pACEBac2 vector with a TEV cleavable N-terminal MBP tag and an mCherry-6xHis-C-
terminal tag. ANXA11 (R235) mutant protein was highly aggregation prone and could 
not be purified, so no further in vitro studies were conducted with this mutant. His-Sumo 
tagged proteins were expressed in E. coli BL21(DE3) in TB autoinduction media by an 
overnight incubation at 25°C. Briefly, cells were centrifuged and lysed using a high 
pressure cell disruption system. Clarified lysate was loaded onto a Ni-Sepharose Excel 
column and purified using standard procedure. Protein containing eluates were pooled, 
and dialysed in 50mM HEPES pH 7.4, 100mM NaCl, and 5% glycerol buffer after 
addition of ULP protease to remove the His-Sumo Tag. Protein was further purified on a 
second Ni-sepharose column to remove the His-Sumo tag followed by a size-exclusion 
column and the fractions containing purified protein were pooled for all subsequent 
experiments. mCherry tagged Annexin WT and its mutants constructs were expressed 
and purified from insect Sf9 cells using standard procedures. After 6 days of infection 
cells were harvested and lysed by homogenising into a resuspension buffer containing 
50mM HEPES pH 7.4, 100mM NaCl, and 5% glycerol, 0.1% CHAPS. Cell Lysates were 
subjected to high speed centrifugation and the clarified lysate was subsequently purified 
using three steps purification protocol including, Ni- Sepharose Excel affinity resin, 
Amylose resin, followed by size exclusion chromatography in the buffer containing 50 
mM HEPES, 225mM NaCl pH 7.4.  
ANXA11 droplet assay 
Phase separation of ANXA11 WT and it mutants was initiated either by changing the 
temperature of the samples from 4°C to RT or by the addition of the crowding 
reagent,10% dextran. Purified ANXA11 protein concentration ranging from 0.1 μM-50 
μM in a total volume of 20 μL were deposited on 8-well glass bottom Ibidi slides, 
incubated at room temperature for ≥30 minutes before being imaged on a Zeiss Axiovert 
200M microscope with Improvision Openlab software using 100X magnification 
objective. ImageJ software was used in all image processing. For all purified proteins n 
≥ 3. 
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In vitro liposome RNA granule reconstitution assay 
     Stress granule cores were purified according to a previously-published method (Jain 
et al. 2016; Khong et al. 2017; Wheeler et al. 2017; Khong et al. 2018) from SH-SY5Y 
cells expressing Emerald-G3BP1 after 1h heat shock at 43oC. Stress granule cores 
were incubated with liposomes in the presence of 1 μM ANXA11 only, 500 μM calcium 
only, or both 1 μM ANXA11 and 500 μM calcium at 37oC for 1 hour.  
Liposome preparation  
Liposomes were prepared with commercially available lipid components from Avanti 
Polar Lipids. Liposome composition was 70% phosphatidylcholine (Avanti #850457C), 
24% phosphatidylethanolamine (Avanti #850757C), 5% cholesterol (Avanti #700000), 
and 1% phosphatidyl-3',5'-bisphosphate (Avanti 850164P). Powdered lipids were 
individually resuspended in chloroform, then mixed together in a glass sample vial and 
evaporated with a dry N2 stream. The mixture was resuspended in a buffered salt 
solution (10mM Na-HEPES, 50mM NaCl, 1mM EDTA, pH 7.4) for 30 minutes, and then 
sonicated in a water bath for 3 minutes to complete resuspension. The lipid mixtures 
were then extruded into large unilamellar vesicles (LUVs) using an Avanti Mini-Extruder 
(Avanti #610023) that was heated to 60oC. For the liposome preparation for microfluidic 
assay, The composition of liposomes without PIP is POPC: 49%, POPS: 10%, POPE: 
20%, SAPI: 15%, Cholesterol: 5% DOPE-ATTO647: 1%. The composition of liposomes 
with PIP3 is POPC: 49%, POPS: 10%, POPE: 20%, SAPI: 10%, PIP 5%, Cholesterol: 
5% DOPE-ATTO647: 1%. 
Giant unilamellar vesicles were prepared from 50% phosphocholine,  10% phospho-
L-serine: 20 % phosphoethanolamine , 10% phosphoinositol (Avanti #850144), 5% 
cholesterol, 5% phosphatidylinositol 3-phosphate(PI3P, Avanti  #850150), 0.05% 
ATTO488 labeled 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine- dissolved in 
chloroform using electroformation method in a Nanion Technologies Ves Prep pro setup 
(Nanion Technologies, Munich, Germany). The lipids were purchased from Avanti 
(Avanti Polar Lipids, Alabaster, USA). 
Liposome Flotation Assay 
 In a thick-wall polycarbonate tube, LUVs and recombinant annexin A11 protein 
were mixed to a final concentration of 0.5mM LUVs and 0.25uM protein in 100L of 
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buffered salt solution (see above). LUV-protein mixture (with or without 100M CaCl2 
added) was incubated for 1 hour at 4oC. Then, 100L of 60% sucrose in PBS was 
added and mixed gently to yield a 30% final sucrose concentration. 250L of 25% 
sucrose was overlaid atop the 30% sucrose layer, and then 50L of PBS was added as 
the final layer in the sucrose gradient. The gradient was centrifuged at 174,000 x g at 
4oC for 1 hour, and then the fractions (top 100L, middle 200L, and bottom 200L) 
were separated. Sample buffer was added to each layer and resolved by 
electrophoresis. 
Lipid strip assay 
        Membrane lipid binding analysis of GST tagged ANXA11 was conducted using 
membrane lipid Strips (Echelon Bioscience), with each spot containing 100 pmol of 
indicated lipids. Membrane were blocked by PBST with 3% BSA for 1hr at room 
temperature, followed by incubated with 0.25g/ml ANXA11-GST (LSBio) for 1hrs in 
blocking buffer, 50M CaCl2 or 1mM EGTA were added to the incubation solution as 
indicated. After washed 3 times with PBST, membrane was blotted with anti-GST 
antibody (ThermoFisher). 
Microfluidic setup and diffusion sizing assay 
The microfluidics setups used here have been described previously(Duffy et al., 
1998; Gang et al., 2018; Qin et al., 2010). For these studies, microfluidic devices were 
fabricated by using polydimethylsiloxane (PDMS) (Sylgard 184 kit, Dow Corning, 
Midland, MI, U.S.A) mixed with black carbon powder (Sigma-Aldrich, Poole, U.K.) to 
maximize the fluorescent signal. The channel is typically with 300 μm in width and 50 
μm in height. The devices were plasma-treated and modified with Tween 20 2% in 
ethanol solution prior to the measurements. The channels were flushed and prefilled 
with buffer. We loaded the sample and buffer at the inlets and withdraw liquid from the 
outlet using a glass syringe (Hamilton, Reno, NE, USA) mounted to a syringe pump 
(Cetoni neMESYS, Cetoni GmbH, Korbussen, Germany). 5 μM mCherry ANXA11 was 
first mixed with liposomes with 500 μM phosphate lipids at different concentrations of 
calcium chloride and then co-flown with the buffer along the channel. The fluorescent 
signal was collected at 4 points along the channel with different diffusion time in order to 
calculate the size of ANXA11. The images were obtained from an inverted microscope 
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(Axio Observer A1, Zeiss , Cambridge, U.K.) coupled to a CCD camera (Evolve 512, 
Photometrics, Tucson, AZ, USA). The hydrodynamic radii of ANXA11 binding to 
liposomes were measured at different calcium concentrations with a microfluidic 
diffusional sizing assay. Enhanced binding was detected from 50 to 1000 µM calcium 
concentration for liposomes with PI3P and from 100 to 5000 µM for those without PI3P. 
In independent experiments, the radius of ANXA11 were determined to be equal to 5.45 
± 0.3 nm. During the short duration of diffusion experiments there was no observed 
influence of calcium ions on protein size, the radius of ANXA11 was 5.51 ± 0.6 nm in the 
presence of 500 µM CaCl2 and 5.27 ± 0.5 nm in the presence of 13.75 mM CaCl2. The 
radius of lipid vesicles was measured to be 14.7 ± 1.1 nm and did not significantly 
change in the presence of calcium concentrations used in the binding experiments. 
Poly A RNA in situ hybridization, single molecule FISH (smFISH) and 
immunofluorescence staining 
        In brief, cells were fixed with 4% paraformaldehyde for 10 mins, then 100% cold 
methanol for 10 mins and followed by 70% ethanol for 10 mins for rehydration, cells 
were then incubated with 1M Tris pH8.0 for 5 mins before incubated with 1ng/l Cy3-
Oligo-dT (30) for rat beta-actin in hybridization buffer (2xSSC with 1mg/mL Yeast tRNA, 
0.005% BSA, 10% Dextran sulfate, 25% formamide) in 37oC overnight. For single 
molecule FISH, rat ActB-Quasar570 smFISH probes were designed using the Stellaris 
Probe Designer software (Biosearch Technologies), smFISH was performed according 
to manufacturer’s instruction using Stellaris buffers (Biosearch Technologies SMF-HB1-
10, SMF-WA1-60 and SMF-WB1-20). After hybridization, cells were washed with 4xSSC 
and 2xSSC once each, and incubated with primary antibody in 2xSSC+ 0.1% triton-X-
100 at 4oC overnight, then washed 3 times with 2xSSC and incubated with fluorescence 
labeled secondary antibody in 2xSSC+ 0.1% triton-X-100 at room temperature for 1hr. 
Coverslips were mounted and imaged with Zeiss Airyscan.  
Live cell imaging 
        Live cell imaging was carried out in phenol red free normal culture medium. For 
U2OS cells, imaging was performed using Zeiss 880 LSM with Airyscan, plan-
apochromatic 63x oil objective (NA=1.4), images were processed with Airyscan 
processing in ZEN software (Zeiss). Axonal trafficking imaging was performed using 
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Nikon spinning disk equipped with 100x oil objective lens (NA=1.4). Time-lapse movies 
of axons were then acquired at 100ms/frame for 30 seconds and displayed in 
kymograph format. 
EM imaging of LAMP1-APEX2 
i3Neurons stably expressing LAMP1-APEX2 were fixed with 2% glutaraldehyde 
(Electron Microscopy Services) in EM buffer (0.1 N sodium cacodylate at pH 7.4 with 2 
mM calcium chloride) for 30 minutes. Cells were washed 3X with EM buffer and then 
exposed to ImmPACT DAB solution (Vector Labs) for 10 minutes. Samples were 
washed with EM buffer an additional 3X and then fixed with 2% glutaraldehyde for at 
least an additional 48 hrs. Samples were washed with buffer and treated with 1% 
reduced osmium tetroxide in 0.1 N cacodylate buffer at pH 7.4 for 1 h on ice, washed 
and en bloc stained with 0.25–1% uranyl acetate in 0.1 N acetate buffer at pH 5.0 
overnight at 4°C, dehydrated with a series of graded ethanol and finally embedded in 
epoxy resins. Ultrathin sections (70 nm) were stained with lead citrate and imaged with 
a JEOL 1200 EXII Transmission Electron Microscope. 
Correlative Light-Electron Microscopy 
        U2OS cells were plated on glass gridded coverslips (Electron Microscopy 
Sciences, Hatfield, PA) and transfected with indicated plasmids. 24hrs after transfection, 
cells were fixed in 2% glutaraldehyde, 2 mM CaCl2 in 0.08 M sodium cacodylate buffer, 
pH 7.2 at RT for 10 minutes and imaged on Zeiss Airyscan to collect light microscopy 
images. Cells were kept in fixative at 4oC for 16hrs and postfixed in 2% osmium 
tetroxide-1.25% potassium ferrocyanide in cacodylate buffer for 30 min followed by 2% 
osmium in cacodylate buffer for another 30 min and processed for Epon embedding. 
Cells imaged by Airyscan were localized on the grid (imprinted in the Epon block). 
Ultrathin sections (60 nm) from the imaged cells were cut and post-stained with uranyl 
acetate/lead citrate and imaged in a Tecnai 12 electron microscope (FEI, Hillsboro, OR) 
operating at 80kV equipped with an Ultrascan 4000 digital camera (Gatan Inc, CA). 
Zebrafish Axonal Imaging 
Zebrafish axonal transport analyses were done as previously described(Drerup and 
Nechiporuk, 2016; Mandal et al., 2018). Briefly, zygotes were injected with plasmid DNA 
encoding fluorescently tagged cargos of interest with expression driven by the 
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5kbneurod promoter (Mandal et al., 2018). At 3 days post-fertilization (dpf) embryos 
were sorted under epifluorescence to identify individuals with tagged cargo expression 
in a few cells of the pLL ganglion. For imaging, embryos were mounted in 1.5% low 
melting point agarose on a glass coverslip, submerged in embryo media containing 
0.02% tricaine and imaged using a 63X/NA=1.2 water objective on an upright LSM800 
confocal microscope (Zeiss). A region of interest (30-200 μm) for each embryo was 
selected in the pLL nerve in which a long stretch of axon was observable in a single 
plane. Scans were taken at 3 frames per second for 500 to 1000 frames.  
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
Imaging Analysis 
For line scan analysis in U2OS cells (Figure 3E, 3I, 4G, 6B, supplemental 3D, 3E, 3F, 
6H), straight line across the RNA granule were drawn as ROI, intensity of ROI from 
each channel were calculated by plot profile tool in Fiji. Fields of view for imaging 
were randomly chosen. For FRAP analysis in U2OS cells (Figure 3C, 4B, supplemental 
4I), three images were acquired prior to photobleaching followed by imaging over the 
course of recovery. Relative intensity of the photobleached ROI were calculated by 
substracting mean intensity of the background from the photobleached ROI region, 
followed by normalized to the mean intensity of the pre-bleach ROI, n represented 
number of ROI. For co-localization analysis (Figure 3E, 3I, 4H, 5B, 5D, supplemental 
1G, 3E, 3F, 4E, 5B, 6B, 6C, 6G), RNA granule or organelles signals were segmented 
using trainable weka segmentation plugin in Fiji, area of colocalization were calculated 
by applying ’AND’ function in image calculator tool for the segmented signals, 
colocalization were determine by >1 pixel overlapping of segmented signal using 
analyze particle tool in Fiji, n represented number of cells. Image acquisition 
and analysis for ANXA11(FL, N-, C-)-RNA granule-lysosome colocalization studies were 
blinded. For trafficking analysis in U2OS (Figure1B, supplemental Figure 1C,1D,1E), 
RNA granule or organelles signals were segmented using trainable weka segmentation 
plugin in Fiji, trajectory of the segmented signals’ centroid were analyzed by Trackmate 
plugin in Fiji, n represents number of cells (Figure 1B) or number of trajectories 
(supplemental Figure 1C,1D,1E). For in vitro RNA granule liposomes reconstitution 
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analysis (Figure6E), images were processed in Fiji using a custom macro. The liposome 
channel was initially gaussian blurred (sigma radius 1.5) to remove shot noise, 
thresholded and masked. The integrated fluorescence intensity of the G3BP1 channel 
within the liposome mask was calculated and normalized to the mask area, n represents 
number of independent experiments. For smFISH signal quantification in growthcone 
(Figure 6J, 7D, supplemental Figure 7C, 7D), areas of growthcone were masked, 
smFISH signal within masked area were segmented using trainable weka segmentation 
plugin in Fiji. Number of segmented smFISH signal were counted using analyze particle 
tool in Fiji, n represented number of growthcones. For rat axonal trafficking analysis 
(Figure 5F, 6H, 7B, Supplemental Figure 1L, 1M, 1N, 5C, 6E, 7B), axonal images were 
straightened, resliced in Fiji to generate kymograph, trajectory of vesicles were 
analyzed by Trackmate plugin in Fiji. Co-trafficking events were defined using the cut-off 
of net displacement >10μm, n represents number of neurons. For zebrafish axonal 
imaging analysis (Figure 7H, Supplemental Figure7E, F, G), embryos expressing both 
constructs in a single cell were selected and imaged sequentially. Transport parameters 
were analyzed using kymograph analysis in the Metamorph software package 
(Molecular Devices), n represents number of zebrafish. Imaging statistical analysis were 
performed using Graphpad Prism 5. For statistical testing, t-tests and ANOVA tests 
were employed on samples with large size (>30); violation of the normality assumption 
were not taken into account because of central limit theorem. F-test was used to access 
the equality of variances of t-test, Bartlett test was use to access the equality 
of variances of ANOVA test. 
LC-MS Data Analysis 
LC-MS/MS (Figure 2D, 2E) raw files were processed by MaxQuant1.6.2.3 software 
(Tyanova et al. 2016) for peptide/protein identification and quantification. MS and 
MS/MS spectra were searched against the Uniprot human proteome database for 
identification with a false discovery rate cutoff level of 1%. Cysteine 
carbamidomethylation was searched as a fixed modification, and protein N-terminal 
acetylation, methionine oxidation as variable modifications. Maxquant output files were 
further analyzed by MS-Stats in R (Choi et al., 2014) for statistical analysis. ToppGene 
Suite ((http://toppgene.cchmc.org) was used for Go-term analysis (Chen et al., 2009).  
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Fitting of the Diffusional Sizing assay 
Diffusional sizing experiments (Figure 2Q) were analyzed using custom written 
script based on previous study (Gang et al. 2018) with minor modifications. 
Concentration profiles were obtained from fluorescence images at 4 positions 
corresponding to 4 different diffusion times and diffusional profiles were fitted to one-
Gaussian model. Hill cooperative binding model was used to fit the change in 
hydrodynamic radius upon ANXA11 binding to lipid vesicles and determine the binding 
constant (equation 1): 
𝒚 = 𝒂 + (𝒃 − 𝒂)
[𝑪𝒂]𝒏
𝑲𝑫
𝒏+[𝑪𝒂]𝒏
  (1) 
Where a is radius of unbound ANXA11, b is radius of vesicle-protein complex, [Ca] is 
calcium concentration in solution, KD is dissociation constant (in M) and n is number of 
cooperative Ca binding sites. OriginPro 2016 was used to fit the experimental data. 
 
DATA AND CODE AVAILABILITY 
Mass spectrometry-based proteomics datasets have been deposited to the PeptideAtlas 
website with the dataset identifier PASS01313 
(http://www.peptideatlas.org/PASS/PASS01313). All other data are either available in 
the main article or in supplemental files. 
 
Supplemental Video 1. RNA granule/lysosome co-trafficking in U2OS cells. 
Related to Figure 1. 
 
Supplemental Video 2. mRNA co-trafficking with lysosomes in U2OS cells. 
Related to Figure 1. 
 
Supplemental Video 3. Opto-ANXA11 associated with RNA granules and 
lysosomes. Related to Figure 6. 
 
Supplemental Video 4. RNA granule co-trafficking with lysosomes and ANXA11 in 
primary rat neuron axons. Related to Figure 7. 
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Supplemental Video 5. ALS-associated ANXA11 mutations disrupt RNA 
granule/lysosome co-trafficking in primary rat neuron axons. Related to Figure 7. 
 
Supplemental Video 6. Caprin co-trafficking with lysosomes in zebrafish axons. 
Related to Figure 7. 
 
Supplemental Video 7. Caprin co-trafficking with ANXA11 in zebrafish axons. 
Related to Figure 7. 
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